Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.5 [1.41-1.6],6.72602326976355e-36,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,0.79 [0.75-0.82],1.17950802253189e-28,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APOA1,Apolipoprotein A-I,Inverse variance weighted,2,3.23 [2.57-4.07],1.17915903412396e-23,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LPA,Apolipoprotein(a),Inverse variance weighted,38,1.11 [1.08-1.14],1.87259847131851e-13,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APOE,Apolipoprotein E,Inverse variance weighted,23,0.84 [0.78-0.9],9.65100014887087e-07,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.22 [1.12-1.34],1.84295123051281e-05,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.26 [1.12-1.41],6.15563764326549e-05,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,10,1.13 [1.06-1.2],8.36550644037316e-05,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CPE,Carboxypeptidase E,Inverse variance weighted,11,0.91 [0.86-0.95],0.000122682875241545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.23 [1.1-1.37],0.000229672536328447,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,16,0.92 [0.87-0.96],0.000622987906998506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PSRC1,Proline/serine-rich coiled-coil protein 1,Inverse variance weighted,4,1.14 [1.06-1.22],0.000646726941424015,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,F10,Coagulation factor X,Inverse variance weighted,9,1.05 [1.02-1.07],0.000720333808041557,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,13,0.83 [0.74-0.93],0.0011307618346097,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.95 [0.92-0.98],0.00157515763666262,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AGRN,Agrin,Inverse variance weighted,17,0.93 [0.88-0.97],0.0016056918181051,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,0.96 [0.93-0.98],0.00197255014305082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.9 [0.84-0.96],0.00227776581684592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,Inverse variance weighted,12,1.09 [1.03-1.15],0.00229271249674815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KHK,Ketohexokinase,Inverse variance weighted,22,1.09 [1.03-1.15],0.00236443625708103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.8 [0.69-0.93],0.00278441561801057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL19,Interleukin-19,Inverse variance weighted,11,1.07 [1.02-1.12],0.00423109573219354,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NTF3,Neurotrophin-3,Inverse variance weighted,8,0.9 [0.84-0.97],0.0043454426424975,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DSG3,Desmoglein-3,Inverse variance weighted,7,0.91 [0.86-0.97],0.00472366517363966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,1.27 [1.08-1.5],0.00472570524550703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,1.02 [1.01-1.04],0.00495170664750663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MPO,Myeloperoxidase,Inverse variance weighted,11,1.07 [1.02-1.12],0.00513290568752227,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PDCD5,Programmed cell death protein 5,Inverse variance weighted,14,0.94 [0.9-0.98],0.00531654734991026,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MFGE8,Lactadherin,Inverse variance weighted,11,1.07 [1.02-1.12],0.00574655962523411,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.94 [0.9-0.98],0.00702976290765695,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SHBG,Sex hormone-binding globulin,Inverse variance weighted,11,0.94 [0.9-0.98],0.0071720914332575,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SNAP25,Synaptosomal-associated protein 25,Inverse variance weighted,2,0.83 [0.72-0.95],0.00807529054818018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.05 [1.01-1.09],0.0100030540752199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,0.96 [0.93-0.99],0.0102539637916444,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.2 [1.04-1.37],0.0108060439951546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.03 [1.01-1.06],0.012306179484696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.08 [1.01-1.14],0.014856844921609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.9 [0.82-0.98],0.0150535452390884,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LCAT,Phosphatidylcholine-sterol acyltransferase,Wald ratio,1,1.2 [1.03-1.39],0.0158613462668848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.93 [0.87-0.99],0.0164811577506859,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,1.56 [1.08-2.26],0.0171961662936246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.88 [0.79-0.98],0.0187332186966806,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1.02 [1-1.05],0.0225580060675864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,21,0.96 [0.93-0.99],0.023566217471388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.95 [0.9-0.99],0.0236999772128215,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.9 [0.83-0.99],0.0238261103204417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.12 [1.01-1.23],0.0238312006243087,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GFER,FAD-linked sulfhydryl oxidase ALR,Wald ratio,1,1.27 [1.03-1.56],0.0240691913631862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LGMN,Legumain,Inverse variance weighted,12,0.95 [0.91-0.99],0.0274235067834561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CTSD,Cathepsin D,Inverse variance weighted,17,1.05 [1.01-1.1],0.027750143456707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.04 [1-1.08],0.0277761491340408,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.07 [1.01-1.13],0.0279673027553924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.08 [1.01-1.15],0.0288807578271034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PAMR1,Inactive serine protease PAMR1,Inverse variance weighted,22,0.97 [0.94-1],0.0302783608844818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.07 [1.01-1.13],0.0307063293527462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.96 [0.92-1],0.0307414683982832,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.06 [1-1.11],0.0314250093989747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MSLN,Mesothelin,Inverse variance weighted,25,1.03 [1-1.06],0.0323997925926922,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.08 [1.01-1.16],0.0334805344145889,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ROBO2,Roundabout homolog 2,Inverse variance weighted,2,0.77 [0.61-0.98],0.0347121864832159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.88 [0.78-0.99],0.0347234150888616,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.88 [0.79-0.99],0.0359785574087483,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SEC31A,Protein transport protein Sec31A,Wald ratio,1,1.18 [1.01-1.37],0.0362250193139534,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGSF9,Protein turtle homolog A,Inverse variance weighted,10,0.95 [0.9-1],0.0380393806416111,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.97 [0.95-1],0.0405252250714666,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SLMAP,Sarcolemmal membrane-associated protein,Inverse variance weighted,2,0.77 [0.59-0.99],0.0406724136688293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,1.02 [1-1.05],0.0424054260101664,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ABL1,Tyrosine-protein kinase ABL1,Wald ratio,1,1.28 [1.01-1.62],0.0442918141763327,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,32,1.03 [1-1.06],0.0444312854486777,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SNX9,Sorting nexin-9,Inverse variance weighted,3,1.16 [1-1.34],0.0476959498895136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,21,1.06 [1-1.12],0.0483441302458036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,27,1.05 [1-1.1],0.0484587538273727,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD83,CD83 antigen,Inverse variance weighted,5,1.08 [1-1.17],0.0487892483503942,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RBPMS2,RNA-binding protein with multiple splicing 2,Wald ratio,1,0.8 [0.64-1],0.0488137104829008,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FURIN,Furin,Wald ratio,1,1.1 [1-1.2],0.0491304015191598,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ICAM4,Intercellular adhesion molecule 4,Inverse variance weighted,3,0.87 [0.76-1],0.0497668144610591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.13 [1-1.27],0.0504782645239238,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.11 [1-1.22],0.0506634576384224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.86 [0.74-1],0.0515582680632883,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.07 [1-1.15],0.0523905416800498,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DOK2,Docking protein 2,Wald ratio,1,0.78 [0.6-1],0.0540093551075599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACAN,Aggrecan core protein,Inverse variance weighted,3,0.86 [0.74-1],0.0545858008087835,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IDUA,Alpha-L-iduronidase,Inverse variance weighted,35,0.98 [0.95-1],0.0559733903733516,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LDLR,Low-density lipoprotein receptor,Wald ratio,1,1.91 [0.98-3.69],0.0561630867059215,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.06 [1-1.13],0.0573816586062501,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.94 [0.88-1],0.0607196488086802,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.94 [0.87-1],0.0615166351327121,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,26,0.97 [0.93-1],0.0643108738439673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VWC2,Brorin,Inverse variance weighted,22,1.04 [1-1.09],0.0654599494255162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MXRA8,Matrix remodeling-associated protein 8,Wald ratio,1,1.22 [0.99-1.52],0.0668191477771878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,THOP1,Thimet oligopeptidase,Inverse variance weighted,5,1.05 [1-1.12],0.0673049470448457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.03 [1-1.07],0.0675130990888176,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.03 [1-1.06],0.0705511115109505,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.19 [0.98-1.44],0.0731479185834088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1.07 [0.99-1.14],0.0734075734529536,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.9 [0.8-1.01],0.0737981799845705,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.98 [0.96-1],0.0741826261261377,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.95 [0.9-1.01],0.0746045840122279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SORD,Sorbitol dehydrogenase,Inverse variance weighted,3,0.92 [0.84-1.01],0.0750659744957955,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,0.96 [0.92-1],0.0754905777168473,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,0.95 [0.89-1.01],0.0756175696966939,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PBLD,Phenazine biosynthesis-like domain-containing protein,Inverse variance weighted,23,1.03 [1-1.06],0.0759204233983937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCG2,Secretogranin-2,Wald ratio,1,1.35 [0.97-1.9],0.0772811433089913,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PEBP1,Phosphatidylethanolamine-binding protein 1,Wald ratio,1,0.84 [0.68-1.02],0.0785115409516153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CHGA,Chromogranin-A,Inverse variance weighted,3,1.07 [0.99-1.16],0.0836613180593291,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NUDT5,ADP-sugar pyrophosphatase,Wald ratio,1,1.27 [0.97-1.68],0.0862900797994984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FBLN2,Fibulin-2,Inverse variance weighted,11,1.04 [0.99-1.09],0.0863663535878268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,1.05 [0.99-1.11],0.0870117320303508,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C4BPB,C4b-binding protein beta chain,Inverse variance weighted,8,1.05 [0.99-1.12],0.0871407557366151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.03 [1-1.07],0.087271404781026,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,0.94 [0.88-1.01],0.087968391582285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.92 [0.84-1.01],0.0895303631299235,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,0.96 [0.92-1.01],0.091022863576562,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,1.37 [0.95-1.98],0.0927637611011018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANXA10,Annexin A10,Wald ratio,1,1.31 [0.96-1.78],0.0937786588502959,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLSCR3,Phospholipid scramblase 3,Wald ratio,1,0.88 [0.75-1.02],0.0938654741345694,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.09 [0.99-1.2],0.0957397094425992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.18 [0.97-1.43],0.0962740822663399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.05 [0.99-1.11],0.0966312836139691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,0.99 [0.97-1],0.0979940230356412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.1 [0.98-1.22],0.0984853482024713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,F12,Coagulation factor XII,Inverse variance weighted,42,1.02 [1-1.04],0.100294123937077,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PENK,Proenkephalin-A,Inverse variance weighted,19,1.04 [0.99-1.09],0.102041077557709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,Inverse variance weighted,8,0.95 [0.9-1.01],0.102061776621629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,22,1.02 [1-1.05],0.10271646757044,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EHBP1,EH domain-binding protein 1,Inverse variance weighted,4,0.92 [0.83-1.02],0.102748969340343,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPINF2,Alpha-2-antiplasmin,Inverse variance weighted,5,0.92 [0.84-1.02],0.102842828170118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,0.97 [0.94-1.01],0.105017695547516,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,1.09 [0.98-1.21],0.10585054138013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.02 [1-1.04],0.106199551201647,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,1.1 [0.98-1.24],0.106533043725279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,Inverse variance weighted,6,0.95 [0.89-1.01],0.107949267967643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.86 [0.72-1.03],0.110583508517679,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MMP1,Interstitial collagenase,Inverse variance weighted,31,0.98 [0.95-1.01],0.112344405795086,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLTP,Phospholipid transfer protein,Inverse variance weighted,19,0.97 [0.94-1.01],0.113922713847956,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.04 [0.99-1.1],0.114427590000582,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OCLN,Occludin,Inverse variance weighted,2,1.1 [0.98-1.24],0.114780516099366,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CPA1,Carboxypeptidase A1,Inverse variance weighted,2,0.88 [0.75-1.03],0.115555700662286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.04 [0.99-1.09],0.116390539950905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PVR,Poliovirus receptor,Inverse variance weighted,27,1.03 [0.99-1.06],0.116485411592654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OGA,Protein O-GlcNAcase,Inverse variance weighted,2,0.9 [0.8-1.03],0.116526712792836,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGA,Fibrinogen alpha chain,Inverse variance weighted,7,0.93 [0.84-1.02],0.116943137095643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,1.06 [0.99-1.14],0.11715282099115,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.94 [0.87-1.02],0.119002267496882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SSNA1,Sjoegren syndrome nuclear autoantigen 1,Wald ratio,1,0.76 [0.54-1.07],0.120310091874514,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TARBP2,RISC-loading complex subunit TARBP2,Wald ratio,1,0.77 [0.54-1.08],0.124111124581276,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.02 [0.99-1.05],0.127974863076017,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCN4,CCN family member 4,Inverse variance weighted,27,1.03 [0.99-1.06],0.128422625936139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,0.95 [0.9-1.01],0.128484226282156,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.33 [0.92-1.91],0.12881791616908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,11,1.04 [0.99-1.09],0.128908551961493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCN5,CCN family member 5,Inverse variance weighted,8,1.1 [0.97-1.25],0.129825002613641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ELN,Elastin,Inverse variance weighted,2,1.18 [0.95-1.45],0.13036286877577,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,3,0.91 [0.8-1.03],0.133211292124198,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.21 [0.94-1.55],0.133520957469573,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",Inverse variance weighted,2,0.93 [0.84-1.02],0.133827951664834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.02 [0.99-1.04],0.134221933141791,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CNTN5,Contactin-5,Inverse variance weighted,28,1.02 [0.99-1.05],0.13677921064329,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.83 [0.65-1.06],0.137263350590603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KITLG,Kit ligand,Wald ratio,1,0.79 [0.58-1.08],0.13817264449766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.05 [0.98-1.13],0.138377869675107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,1.06 [0.98-1.13],0.138502712849868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC3B,Tetranectin,Inverse variance weighted,7,0.95 [0.89-1.02],0.139763053056721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ENO3,Beta-enolase,Wald ratio,1,1.14 [0.96-1.37],0.139795090543726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PRSS8,Prostasin,Inverse variance weighted,5,1.09 [0.97-1.22],0.140224717822054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.97 [0.92-1.01],0.142941415583723,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PCBP2,Poly(rC)-binding protein 2,Wald ratio,1,0.79 [0.58-1.08],0.144570130466537,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SOST,Sclerostin,Wald ratio,1,1.24 [0.93-1.67],0.145628782967298,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LGALS9,Galectin-9,Inverse variance weighted,26,0.98 [0.94-1.01],0.147887420213726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SPON2,Spondin-2,Inverse variance weighted,4,0.95 [0.89-1.02],0.148734410513532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.98 [0.95-1.01],0.150768808698784,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.04 [0.99-1.09],0.15182988484784,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MTSS1,Protein MTSS 1,Wald ratio,1,1.27 [0.92-1.75],0.153548815747569,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.89 [0.76-1.04],0.153903286192653,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NID1,Nidogen-1,Inverse variance weighted,6,0.96 [0.91-1.02],0.153939524462733,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,20,1.03 [0.99-1.07],0.155349715946951,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.02 [0.99-1.05],0.15758589010057,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.91 [0.81-1.04],0.158026266691068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ERBB3,Receptor tyrosine-protein kinase erbB-3,Inverse variance weighted,7,0.96 [0.9-1.02],0.159385036260734,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,Wald ratio,1,0.85 [0.67-1.07],0.160906502424262,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SNCA,Alpha-synuclein,Wald ratio,1,0.77 [0.54-1.11],0.162585969782395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.97 [0.93-1.01],0.163574452599186,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,0.94 [0.86-1.03],0.163821398425236,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,1.12 [0.95-1.31],0.166997469171107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.91 [0.79-1.04],0.167136967647817,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.93 [0.84-1.03],0.167826046818416,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.99 [0.97-1.01],0.16859608487628,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",Inverse variance weighted,11,1.04 [0.98-1.11],0.168670778590786,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HMOX2,Heme oxygenase 2,Inverse variance weighted,2,0.84 [0.65-1.08],0.1694848888376,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,1.06 [0.97-1.16],0.169559569141304,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.92 [0.82-1.04],0.169893985445932,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,0.95 [0.88-1.02],0.170635970632637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MEP1A,Meprin A subunit alpha,Inverse variance weighted,8,0.96 [0.91-1.02],0.171903083202965,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,0.98 [0.95-1.01],0.175370997842292,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.04 [0.98-1.09],0.176375510094154,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.1 [0.96-1.26],0.176603833581433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,QDPR,Dihydropteridine reductase,Inverse variance weighted,8,1.06 [0.98-1.14],0.178843507791797,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.05 [0.98-1.12],0.179453067811187,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BCAN,Brevican core protein,Inverse variance weighted,3,1.05 [0.98-1.12],0.182007255124504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ATOX1,Copper transport protein ATOX1,Wald ratio,1,1.16 [0.93-1.45],0.18230780790442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TP53I3,Quinone oxidoreductase PIG3,Inverse variance weighted,17,0.98 [0.94-1.01],0.183016791531246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APOD,Apolipoprotein D,Inverse variance weighted,7,1.03 [0.98-1.09],0.183479137717854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PGA4,Pepsin A-4,Inverse variance weighted,2,1.15 [0.93-1.43],0.184056173515159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.03 [0.99-1.07],0.185666660908883,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.84 [0.65-1.09],0.186098890451754,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MAPK9,Mitogen-activated protein kinase 9,Inverse variance weighted,2,0.92 [0.8-1.04],0.186804430111535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,0.81 [0.59-1.11],0.187018724668769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.1 [0.95-1.27],0.191707122758967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.04 [0.98-1.1],0.19233569438723,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,1.02 [0.99-1.06],0.192387611837514,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,18,0.97 [0.93-1.01],0.19290508006991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,1.17 [0.92-1.49],0.193939160832242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NRP2,Neuropilin-2,Inverse variance weighted,11,0.97 [0.91-1.02],0.195585641154654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RTBDN,Retbindin,Inverse variance weighted,3,0.94 [0.86-1.03],0.19774271720948,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.93 [0.83-1.04],0.201936290643301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.04 [0.98-1.1],0.202109860295716,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PROC,Vitamin K-dependent protein C,Inverse variance weighted,4,0.83 [0.63-1.1],0.203678852501857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,0.97 [0.91-1.02],0.207956436815891,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NUMB,Protein numb homolog,Wald ratio,1,0.86 [0.69-1.09],0.209363855520023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AREG,Amphiregulin,Inverse variance weighted,3,0.9 [0.77-1.06],0.212599237119027,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,1.07 [0.96-1.18],0.213610790753335,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GFRAL,GDNF family receptor alpha-like,Inverse variance weighted,33,0.98 [0.96-1.01],0.214149988111585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NIT2,Omega-amidase NIT2,Inverse variance weighted,3,0.88 [0.72-1.08],0.219622690888639,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Inverse variance weighted,10,1.05 [0.97-1.12],0.220675861988804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FABP5,Fatty acid-binding protein 5,Wald ratio,1,1.07 [0.96-1.2],0.221060181974949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DNPEP,Aspartyl aminopeptidase,Inverse variance weighted,2,0.83 [0.62-1.12],0.221235871176971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ITGA5,Integrin alpha-5,Wald ratio,1,0.85 [0.65-1.11],0.221867643422757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.97 [0.91-1.02],0.222734326267088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.98 [0.96-1.01],0.223458315483736,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ASAH1,Acid ceramidase,Inverse variance weighted,20,1.02 [0.99-1.05],0.223787844251239,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SNAP29,Synaptosomal-associated protein 29,Wald ratio,1,1.17 [0.91-1.5],0.223944537432122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.02 [0.99-1.07],0.224264363941736,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,1.22 [0.88-1.68],0.225861708847817,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.97 [0.93-1.02],0.225888935143021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCN3,CCN family member 3,Inverse variance weighted,19,1.03 [0.98-1.08],0.227121151049909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CPB2,Carboxypeptidase B2,Inverse variance weighted,27,1.02 [0.99-1.07],0.227304589630091,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.03 [0.98-1.09],0.22967327518253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANG,Angiogenin,Inverse variance weighted,19,1.02 [0.99-1.06],0.230295840073029,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,0.99 [0.96-1.01],0.23194062475213,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.09 [0.95-1.25],0.232655216558046,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OPLAH,5-oxoprolinase,Inverse variance weighted,4,1.05 [0.97-1.13],0.232893173991921,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.14 [0.92-1.43],0.233368208268306,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.02 [0.99-1.06],0.233454112084633,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,F11,Coagulation factor XI,Inverse variance weighted,19,1.04 [0.98-1.1],0.233698839752445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,STAB2,Stabilin-2,Inverse variance weighted,20,0.98 [0.95-1.01],0.233891528792062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.96 [0.89-1.03],0.234023596433223,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,0.99 [0.96-1.01],0.236532933844166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1.06 [0.96-1.17],0.239401446269218,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,10,0.97 [0.92-1.02],0.241913631916471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,F2,Prothrombin,Inverse variance weighted,6,1.05 [0.97-1.14],0.241992295904131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.04 [0.97-1.12],0.24600149699689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAT,Linker for activation of T-cells family member 1,Wald ratio,1,1.25 [0.86-1.82],0.246202288680724,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL17C,Interleukin-17C,Inverse variance weighted,3,1.07 [0.95-1.2],0.251027727743859,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MB,Myoglobin,Wald ratio,1,1.28 [0.84-1.95],0.255319357495035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NFKBIE,NF-kappa-B inhibitor epsilon,Inverse variance weighted,2,0.97 [0.91-1.03],0.255656590838532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.07 [0.96-1.19],0.256418093554099,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,Wald ratio,1,0.82 [0.58-1.16],0.256595269044726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,17,1.02 [0.99-1.06],0.259782542519249,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.01 [0.99-1.04],0.260431229136891,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGFBP3,Fibroblast growth factor-binding protein 3,Inverse variance weighted,19,0.98 [0.94-1.02],0.261717954998428,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANGPTL2,Angiopoietin-related protein 2,Wald ratio,1,1.24 [0.85-1.82],0.262232397317735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1.05 [0.96-1.15],0.262427623657242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.08 [0.94-1.23],0.264598840612132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,1.11 [0.92-1.33],0.26499011927618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.02 [0.98-1.06],0.26523593916117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,UPB1,Beta-ureidopropionase,Inverse variance weighted,3,1.14 [0.9-1.45],0.265462278402151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CTSF,Cathepsin F,Inverse variance weighted,10,1.04 [0.97-1.1],0.265763035296964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CDH5,Cadherin-5,Inverse variance weighted,3,1.04 [0.97-1.11],0.26625011185892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.03 [0.98-1.08],0.266603799036193,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,0.95 [0.86-1.04],0.268174624808071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NRP1,Neuropilin-1,Inverse variance weighted,12,0.98 [0.93-1.02],0.268620539182975,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,47,0.99 [0.97-1.01],0.27057384458752,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,3,1.22 [0.86-1.73],0.270895590221824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.06 [0.95-1.18],0.271359030078234,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MUC13,Mucin-13,Inverse variance weighted,9,0.97 [0.91-1.03],0.271426294232493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,F7,Coagulation factor VII,Inverse variance weighted,21,1.02 [0.98-1.07],0.27579678684067,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.97 [0.93-1.02],0.276830460711022,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.04 [0.97-1.12],0.277882252298624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCAMP3,Secretory carrier-associated membrane protein 3,Wald ratio,1,0.89 [0.72-1.1],0.281470396069891,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.8 [0.54-1.2],0.282345245169328,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.95 [0.87-1.04],0.283656144857149,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.03 [0.98-1.08],0.28425473388697,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NFASC,Neurofascin,Inverse variance weighted,15,0.98 [0.94-1.02],0.28479002670296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GSTA3,Glutathione S-transferase A3,Inverse variance weighted,7,1.12 [0.91-1.36],0.286209755719978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.04 [0.96-1.13],0.286843309954672,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CEP20,Centrosomal protein 20,Inverse variance weighted,2,1.12 [0.91-1.38],0.288072790247359,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.96 [0.88-1.04],0.290481530012197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KLK14,Kallikrein-14,Inverse variance weighted,15,1.02 [0.98-1.05],0.293575118903734,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EPPK1,Epiplakin,Inverse variance weighted,33,0.99 [0.96-1.01],0.293978356963569,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.03 [0.98-1.08],0.294918857943986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.93 [0.82-1.06],0.295742965900704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.02 [0.98-1.06],0.299885521135922,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.91 [0.77-1.08],0.300127652138911,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GSTA1,Glutathione S-transferase A1,Inverse variance weighted,7,1.11 [0.91-1.35],0.302121501268126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.91 [0.76-1.09],0.30564214024713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,0.97 [0.92-1.03],0.30693659692539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,1.01 [0.99-1.03],0.307569749887797,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MMP10,Stromelysin-2,Inverse variance weighted,22,0.98 [0.94-1.02],0.307625787558586,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLUL1,Clusterin-like protein 1,Inverse variance weighted,18,1.01 [0.99-1.04],0.310182845257776,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NPY,Pro-neuropeptide Y,Inverse variance weighted,3,0.95 [0.86-1.05],0.31194471081498,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,1.02 [0.99-1.05],0.312064417872623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TYMP,Thymidine phosphorylase,Inverse variance weighted,4,1.04 [0.96-1.12],0.312330501182063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DBI,Acyl-CoA-binding protein,Inverse variance weighted,9,0.97 [0.92-1.03],0.317466317461034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MYDGF,Myeloid-derived growth factor,Wald ratio,1,0.89 [0.7-1.12],0.318205263288945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.03 [0.97-1.1],0.321662136478102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,0.96 [0.9-1.04],0.322398949936201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SELL,L-selectin,Inverse variance weighted,18,0.98 [0.95-1.02],0.323916177383758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PALM2,Paralemmin-2,Inverse variance weighted,8,1.03 [0.97-1.1],0.324116022959388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,3,1.04 [0.96-1.13],0.325258349692085,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.03 [0.97-1.08],0.325565131471879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.97 [0.9-1.03],0.327752087134245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,0.96 [0.89-1.04],0.329052532054286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MAMDC4,Apical endosomal glycoprotein,Inverse variance weighted,6,1.03 [0.97-1.09],0.329137767250208,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,0.98 [0.93-1.03],0.329308139520824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CFH,Complement factor H,Inverse variance weighted,19,0.98 [0.93-1.02],0.332214037769413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,4,1.05 [0.95-1.16],0.333108640095855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,Wald ratio,1,1.06 [0.94-1.2],0.333402578456348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,1.07 [0.94-1.21],0.333719387272478,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.98 [0.93-1.02],0.335565863136155,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Wald ratio,1,0.9 [0.71-1.12],0.336043334871889,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.98 [0.93-1.02],0.337113496491026,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CTSB,Cathepsin B,Inverse variance weighted,26,1.01 [0.99-1.04],0.337391265672376,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.95 [0.86-1.05],0.339945355029631,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TF,Serotransferrin,Inverse variance weighted,11,0.98 [0.93-1.03],0.341696356619824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.08 [0.92-1.26],0.347510184253452,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,1.06 [0.94-1.2],0.349562029081317,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TCOF1,Treacle protein,Wald ratio,1,0.86 [0.63-1.18],0.352670658999611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,1.03 [0.97-1.09],0.354209146579916,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.01 [0.99-1.04],0.357283860314401,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LGALS8,Galectin-8,Inverse variance weighted,7,0.97 [0.9-1.04],0.360181883827054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TIMP3,Metalloproteinase inhibitor 3,Inverse variance weighted,23,1.01 [0.99-1.04],0.361093005271132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,0.84 [0.57-1.23],0.364951162027966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.08 [0.91-1.29],0.366277754709655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,3,0.79 [0.47-1.33],0.368036932256565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLAT,Tissue-type plasminogen activator,Wald ratio,1,0.87 [0.64-1.18],0.369233186476698,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.05 [0.95-1.16],0.369904909336093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,0.99 [0.98-1.01],0.370345992666983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL22,C-C motif chemokine 22,Inverse variance weighted,6,0.97 [0.9-1.04],0.371877799571334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.08 [0.92-1.26],0.373244498918243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.05 [0.95-1.16],0.373303240270299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,0.97 [0.9-1.04],0.375114562765746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,XCL1,Lymphotactin,Inverse variance weighted,31,0.99 [0.97-1.01],0.375224580200148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL15,Interleukin-15,Wald ratio,1,1.96 [0.44-8.71],0.375932759881386,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FASLG,Tumor necrosis factor ligand superfamily member 6,Wald ratio,1,1.11 [0.88-1.4],0.3773978619976,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,4,1.07 [0.93-1.23],0.37820912839757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.02 [0.98-1.05],0.378664152757523,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,4,1.06 [0.93-1.2],0.37927519815301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.07 [0.92-1.24],0.379417830240035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.07 [0.92-1.24],0.381264577355907,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MMP8,Neutrophil collagenase,Inverse variance weighted,17,1.01 [0.98-1.05],0.382816704724439,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.01 [0.98-1.05],0.382826637540055,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD34,Hematopoietic progenitor cell antigen CD34,Wald ratio,1,1.13 [0.86-1.48],0.383137806077746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COLEC12,Collectin-12,Inverse variance weighted,11,0.97 [0.91-1.04],0.386345610781367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,19,1.02 [0.98-1.06],0.386360894934061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,1.02 [0.98-1.05],0.392289238686866,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MARCO,Macrophage receptor MARCO,Inverse variance weighted,10,0.98 [0.93-1.03],0.392870243949887,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TMSB10,Thymosin beta-10,Wald ratio,1,1.13 [0.86-1.48],0.392949168963701,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NUDT16,U8 snoRNA-decapping enzyme,Inverse variance weighted,4,0.97 [0.91-1.04],0.394233630090358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.03 [0.97-1.09],0.394824200962768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CPB1,Carboxypeptidase B,Wald ratio,1,1.07 [0.92-1.23],0.395442695180994,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.99 [0.97-1.01],0.395846224357741,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.97 [0.92-1.03],0.395908883497949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD27,CD27 antigen,Inverse variance weighted,9,0.98 [0.94-1.03],0.396519715366912,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,21,0.98 [0.94-1.03],0.399832121553399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL10,Interleukin-10,Wald ratio,1,0.94 [0.8-1.09],0.401366026005146,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SELE,E-selectin,Inverse variance weighted,4,0.93 [0.8-1.09],0.402718253670013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.96 [0.86-1.06],0.403146029866933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.04 [0.95-1.14],0.405216070636277,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KLB,Beta-klotho,Inverse variance weighted,32,1.01 [0.99-1.03],0.405360108677293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MET,Hepatocyte growth factor receptor,Inverse variance weighted,5,1.1 [0.88-1.38],0.406610329581216,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.19 [0.79-1.8],0.4114718316164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,0.99 [0.96-1.01],0.417068773250389,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTPRF,Receptor-type tyrosine-protein phosphatase F,Inverse variance weighted,2,0.89 [0.67-1.18],0.419327296709561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MOCS2,Molybdopterin synthase catalytic subunit,Inverse variance weighted,31,0.98 [0.94-1.02],0.4194229949884,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1.02 [0.97-1.07],0.421315907687388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.97 [0.92-1.04],0.424077067574909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.99 [0.95-1.02],0.42478519350956,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,0.95 [0.83-1.08],0.426731737477199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NCAM2,Neural cell adhesion molecule 2,Inverse variance weighted,30,0.99 [0.96-1.02],0.4335796028911,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.01 [0.99-1.03],0.437875145618618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.01 [0.98-1.04],0.437989154556687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.85 [0.57-1.28],0.43977070145297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C19orf12,Protein C19orf12,Wald ratio,1,0.85 [0.56-1.28],0.440770635594412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1.01 [0.98-1.05],0.442169486740857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.98 [0.94-1.03],0.443133526883744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPINH1,Serpin H1,Inverse variance weighted,3,1.07 [0.9-1.26],0.445581825245624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,31,1.01 [0.99-1.03],0.447313438444395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.03 [0.95-1.11],0.449756602050568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AMBP,Protein AMBP,Inverse variance weighted,3,1.06 [0.91-1.25],0.450477059071891,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,4,1.04 [0.93-1.16],0.451644918428755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.93 [0.77-1.13],0.453304313483275,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EDN1,Endothelin-1,Inverse variance weighted,3,1.04 [0.94-1.15],0.456636864866157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPINA4,Kallistatin,Inverse variance weighted,26,1.01 [0.99-1.03],0.456640126911706,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TMPRSS15,Enteropeptidase,Inverse variance weighted,3,1.05 [0.93-1.18],0.457452826284535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,1.03 [0.95-1.12],0.460426648690828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.72 [0.29-1.75],0.464132278451274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.14 [0.81-1.6],0.465373391950737,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HEPACAM2,HEPACAM family member 2,Wald ratio,1,0.74 [0.32-1.68],0.466231542835154,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.98 [0.94-1.03],0.466904224431966,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DTYMK,Thymidylate kinase,Inverse variance weighted,4,1.12 [0.82-1.55],0.467470833088156,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.19 [0.75-1.88],0.468688373123251,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,0.98 [0.94-1.03],0.470650062335045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,Inverse variance weighted,4,0.97 [0.89-1.06],0.470989261435634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GRN,Progranulin,Inverse variance weighted,7,0.98 [0.91-1.04],0.472326939573481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,0.99 [0.95-1.02],0.473887827832031,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.01 [0.99-1.02],0.474268978565943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.97 [0.91-1.05],0.478366510066908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,7,0.96 [0.85-1.08],0.479065297567231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.01 [0.98-1.04],0.481445133420211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.97 [0.89-1.05],0.486350542855457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.99 [0.96-1.02],0.488410441025916,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CTSO,Cathepsin O,Inverse variance weighted,6,0.97 [0.91-1.05],0.491003266830506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,0.96 [0.87-1.07],0.492598897843138,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SDC1,Syndecan-1,Inverse variance weighted,2,0.91 [0.7-1.18],0.492868340426982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.01 [0.98-1.05],0.495805438118593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HPSE,Heparanase,Wald ratio,1,0.98 [0.92-1.04],0.498993281099634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DNAJB14,DnaJ homolog subfamily B member 14,Wald ratio,1,0.9 [0.65-1.23],0.499363496417091,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OSM,Oncostatin-M,Wald ratio,1,1.08 [0.86-1.36],0.499413693161775,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PYY,Peptide YY,Inverse variance weighted,6,1.02 [0.96-1.09],0.500546096270342,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SHMT1,"Serine hydroxymethyltransferase, cytosolic",Inverse variance weighted,42,1.01 [0.98-1.03],0.501901109767128,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,0.99 [0.95-1.03],0.502640427020035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,1.01 [0.98-1.04],0.509926908408446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,0.99 [0.97-1.02],0.517124918044638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,F11R,Junctional adhesion molecule A,Wald ratio,1,0.92 [0.71-1.19],0.517157558517551,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TALDO1,Transaldolase,Inverse variance weighted,3,1.06 [0.88-1.28],0.521090866742565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.05 [0.91-1.21],0.523900045559614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CREG1,Protein CREG1,Inverse variance weighted,3,0.97 [0.89-1.06],0.524772351960272,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.9 [0.64-1.26],0.525143086059497,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1.03 [0.94-1.14],0.526501894116463,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.04 [0.92-1.17],0.527797842483717,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.96 [0.86-1.08],0.530004101710312,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RSPO3,R-spondin-3,Inverse variance weighted,6,0.97 [0.9-1.06],0.530692207482353,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,17,1.02 [0.96-1.09],0.530884757364239,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.92 [0.69-1.21],0.532531319538104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DNMBP,Dynamin-binding protein,Inverse variance weighted,5,0.96 [0.85-1.09],0.536583571397785,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,1.01 [0.98-1.03],0.536793550725779,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IPCEF1,Interactor protein for cytohesin exchange factors 1,Wald ratio,1,1.06 [0.88-1.29],0.540133953990572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.04 [0.92-1.17],0.541084150419274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.04 [0.92-1.16],0.544430799416244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CHGB,Secretogranin-1,Inverse variance weighted,27,0.99 [0.96-1.02],0.545451704004442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IQGAP2,Ras GTPase-activating-like protein IQGAP2,Inverse variance weighted,2,0.97 [0.87-1.08],0.546392960179842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.02 [0.95-1.09],0.548871316075538,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.04 [0.91-1.2],0.551828168346291,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PGF,Placenta growth factor,Inverse variance weighted,2,0.79 [0.36-1.72],0.553239355290098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CRISP3,Cysteine-rich secretory protein 3,Inverse variance weighted,41,1.01 [0.98-1.03],0.553452686827396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.98 [0.93-1.04],0.555149723189369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.98 [0.92-1.04],0.55751665391334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.04 [0.91-1.2],0.557814597108331,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AP3B1,AP-3 complex subunit beta-1,Wald ratio,1,0.9 [0.63-1.28],0.55884137925043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SORT1,Sortilin,Inverse variance weighted,3,0.79 [0.36-1.73],0.558924042256858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Inverse variance weighted,3,1.03 [0.93-1.14],0.558990262378248,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.98 [0.91-1.05],0.562058611602332,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,0.97 [0.87-1.08],0.562469132098292,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CFI,Complement factor I,Inverse variance weighted,6,1.03 [0.94-1.12],0.564199784758953,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FCN1,Ficolin-1,Inverse variance weighted,28,0.99 [0.95-1.03],0.566495967854769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FABP6,Gastrotropin,Wald ratio,1,0.97 [0.86-1.09],0.569920601457846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GBP1,Guanylate-binding protein 1,Inverse variance weighted,10,0.99 [0.94-1.03],0.570725332971638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.99 [0.96-1.02],0.570933143358977,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.05 [0.89-1.24],0.573425711620819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.02 [0.95-1.1],0.578423402874005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,Inverse variance weighted,2,0.92 [0.69-1.23],0.578620243350462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.09 [0.81-1.46],0.583194365004068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.93 [0.71-1.21],0.583606490610933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL18,Interleukin-18,Inverse variance weighted,16,0.98 [0.9-1.06],0.585047390369278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HEXIM1,Protein HEXIM1,Wald ratio,1,0.91 [0.64-1.29],0.585290212198098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPIND1,Heparin cofactor 2,Wald ratio,1,1.05 [0.88-1.27],0.586167681975143,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C5,Complement C5,Inverse variance weighted,3,1.03 [0.93-1.14],0.587007549553838,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD209,CD209 antigen,Inverse variance weighted,15,0.98 [0.93-1.04],0.590593272506654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HJV,Hemojuvelin,Wald ratio,1,1.02 [0.94-1.12],0.590849068802072,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFSF14,Tumor necrosis factor ligand superfamily member 14,Inverse variance weighted,11,0.99 [0.94-1.03],0.592864081871787,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COL2A1,Collagen alpha-1(II) chain,Inverse variance weighted,42,0.99 [0.97-1.01],0.594105993393416,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.99 [0.97-1.02],0.599389236134834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DCXR,L-xylulose reductase,Inverse variance weighted,2,0.98 [0.89-1.07],0.602731233081425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CNTN3,Contactin-3,Inverse variance weighted,14,0.99 [0.94-1.04],0.603097453824885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACY1,Aminoacylase-1,Inverse variance weighted,4,0.96 [0.82-1.12],0.604105004969022,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,Inverse variance weighted,17,1.02 [0.96-1.08],0.607182067552883,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MVK,Mevalonate kinase,Inverse variance weighted,2,0.96 [0.81-1.13],0.607493216429893,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SPP1,Osteopontin,Inverse variance weighted,8,0.96 [0.83-1.11],0.611036883042988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,Inverse variance weighted,2,1.06 [0.85-1.32],0.612129203777826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,43,0.99 [0.96-1.02],0.613387603861902,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.99 [0.94-1.03],0.616611158959354,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.99 [0.93-1.04],0.617212146257009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.93 [0.69-1.25],0.617385137620814,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SELPLG,P-selectin glycoprotein ligand 1,Inverse variance weighted,6,1.01 [0.98-1.03],0.618380784838751,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LMNB2,Lamin-B2,Wald ratio,1,1.1 [0.75-1.63],0.618799424057409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLIN3,Perilipin-3,Wald ratio,1,0.95 [0.76-1.18],0.619230327359035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD58,Lymphocyte function-associated antigen 3,Inverse variance weighted,4,0.98 [0.89-1.07],0.619602427071671,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.99 [0.94-1.04],0.620794058290684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.93 [0.7-1.24],0.62180714321126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FAM3D,Protein FAM3D,Inverse variance weighted,17,0.98 [0.91-1.06],0.621989227818899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,11,0.99 [0.93-1.04],0.622763750630942,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PAXX,Protein PAXX,Inverse variance weighted,3,0.98 [0.89-1.07],0.623621507213606,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OXT,Oxytocin-neurophysin 1,Inverse variance weighted,23,1.01 [0.98-1.04],0.628614960193992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1.01 [0.96-1.06],0.631126674057094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL19,C-C motif chemokine 19,Inverse variance weighted,2,0.96 [0.83-1.12],0.631647218944749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD302,CD302 antigen,Inverse variance weighted,9,0.99 [0.93-1.05],0.632378995805934,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,9,0.97 [0.85-1.11],0.637006370781518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.98 [0.9-1.07],0.641422288685588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.96 [0.82-1.13],0.641554530792421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.96 [0.81-1.14],0.6426025063532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CFD,Complement factor D,Inverse variance weighted,11,1.01 [0.95-1.08],0.642833915553508,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PKD1,Polycystin-1,Inverse variance weighted,12,1.02 [0.95-1.09],0.644983320635987,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DNAJB6,DnaJ homolog subfamily B member 6,Inverse variance weighted,4,1.02 [0.95-1.09],0.645411779679841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADIPOQ,Adiponectin,Inverse variance weighted,13,0.99 [0.93-1.04],0.646758023135489,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CEMIP2,Cell surface hyaluronidase,Inverse variance weighted,4,1.04 [0.89-1.21],0.64729229062785,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.03 [0.91-1.16],0.64750151121041,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PDLIM7,PDZ and LIM domain protein 7,Wald ratio,1,1.09 [0.75-1.59],0.647679890350396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KLK11,Kallikrein-11,Inverse variance weighted,6,1.01 [0.97-1.05],0.650479410394389,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.98 [0.9-1.07],0.650947945146782,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.94 [0.73-1.22],0.651811462077179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MME,Neprilysin,Inverse variance weighted,3,0.91 [0.59-1.39],0.65226099937045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VSNL1,Visinin-like protein 1,Inverse variance weighted,8,1.03 [0.9-1.17],0.652781107349692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCLY,Selenocysteine lyase,Inverse variance weighted,4,0.98 [0.89-1.08],0.652938726340536,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.02 [0.95-1.09],0.653948688424484,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AP1G2,AP-1 complex subunit gamma-like 2,Inverse variance weighted,4,1.02 [0.94-1.1],0.656145530693537,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,0.97 [0.87-1.09],0.656235292399976,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,0.99 [0.93-1.05],0.660180457504317,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,0.98 [0.87-1.09],0.66202941509938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HCLS1,Hematopoietic lineage cell-specific protein,Inverse variance weighted,2,1.05 [0.83-1.33],0.662096256420567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CTSL,Cathepsin L1,Wald ratio,1,1.08 [0.76-1.52],0.662224154655476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXCL6,C-X-C motif chemokine 6,Inverse variance weighted,26,0.98 [0.91-1.07],0.662732959092528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SPRR3,Small proline-rich protein 3,Inverse variance weighted,11,1.01 [0.96-1.07],0.672182196436469,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.03 [0.89-1.19],0.672620187115374,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.03 [0.9-1.18],0.675229683115138,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,0.99 [0.95-1.03],0.677007247485024,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.94 [0.7-1.26],0.677691933292605,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Inverse variance weighted,12,0.99 [0.95-1.04],0.67960887273111,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GSN,Gelsolin,Inverse variance weighted,5,0.97 [0.86-1.1],0.681081094835194,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.02 [0.94-1.09],0.681643954253107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,STAT2,Signal transducer and activator of transcription 2,Inverse variance weighted,3,0.99 [0.92-1.06],0.684457512142028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.99 [0.95-1.04],0.68693250746417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCN1,CCN family member 1,Inverse variance weighted,2,1.03 [0.89-1.19],0.68845120751035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1.01 [0.98-1.04],0.689647089518801,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.99 [0.94-1.04],0.690628387535219,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,1.07 [0.77-1.5],0.69225005278588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RNASE6,Ribonuclease K6,Inverse variance weighted,15,0.99 [0.95-1.03],0.692407358514814,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1.01 [0.96-1.06],0.692419032552927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ATRN,"Attractin, Isoform 2",Inverse variance weighted,12,0.99 [0.95-1.04],0.692581875371446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,2,0.96 [0.77-1.19],0.694769514498953,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,34,1 [0.97-1.02],0.696230099249721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADH1B,All-trans-retinol dehydrogenase,Inverse variance weighted,3,1.02 [0.93-1.12],0.696241282631618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PDIA4,Protein disulfide-isomerase A4,Wald ratio,1,0.96 [0.78-1.18],0.697140225713973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1 [0.98-1.03],0.699288813198276,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CAPG,Macrophage-capping protein,Inverse variance weighted,33,0.99 [0.97-1.02],0.702860535132465,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,17,0.99 [0.96-1.03],0.703675582397008,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNN,Tenascin-N,Inverse variance weighted,44,1 [0.98-1.03],0.704167609674053,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,0.99 [0.97-1.02],0.704945745949232,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DPT,Dermatopontin,Inverse variance weighted,21,1.01 [0.97-1.05],0.70499008970782,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,1.01 [0.96-1.06],0.70640944119999,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NECTIN4,Nectin-4,Inverse variance weighted,7,1.01 [0.96-1.06],0.70747275741935,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NECTIN2,Nectin-2,Inverse variance weighted,5,0.96 [0.76-1.21],0.711342938567969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",Wald ratio,1,0.94 [0.68-1.3],0.71150519769158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.98 [0.89-1.09],0.711664337883687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1 [0.97-1.02],0.713773182931325,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LGALS4,Galectin-4,Inverse variance weighted,4,0.97 [0.81-1.16],0.715035334759055,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,0.99 [0.94-1.04],0.715276596035507,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MDK,Midkine,Inverse variance weighted,4,1.02 [0.92-1.13],0.715461190394761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FETUB,Fetuin-B,Inverse variance weighted,20,0.99 [0.96-1.03],0.715631526942435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.99 [0.95-1.04],0.715674299950468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,1.01 [0.98-1.03],0.715773740192691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KYNU,Kynureninase,Inverse variance weighted,8,1.01 [0.95-1.08],0.716621653423164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FAM3B,Protein FAM3B,Inverse variance weighted,18,0.99 [0.97-1.02],0.719504031578927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PALM,Paralemmin-1,Inverse variance weighted,6,1.01 [0.94-1.1],0.72025892981299,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.01 [0.97-1.04],0.720373683298975,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DSC2,Desmocollin-2,Inverse variance weighted,9,0.99 [0.94-1.04],0.720441465722742,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.99 [0.95-1.03],0.721907378599051,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.01 [0.94-1.09],0.722654850059118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TTR,Transthyretin,Inverse variance weighted,3,0.98 [0.86-1.11],0.722697875362989,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.97 [0.84-1.13],0.723872531939068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.04 [0.85-1.27],0.725253892576577,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,3,1.02 [0.91-1.15],0.726298520953614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.02 [0.93-1.11],0.727415559237045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CSTB,Cystatin-B,Inverse variance weighted,28,0.99 [0.96-1.03],0.727702786018669,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NUCB2,Nucleobindin-2,Inverse variance weighted,24,0.99 [0.95-1.04],0.728536413886613,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPING1,Plasma protease C1 inhibitor,Inverse variance weighted,9,1.01 [0.96-1.06],0.728674446494367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,Inverse variance weighted,34,1 [0.98-1.03],0.729993949988739,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CALB2,Calretinin,Wald ratio,1,0.96 [0.74-1.24],0.733284809861062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CDH2,Cadherin-2,Inverse variance weighted,3,1.03 [0.85-1.26],0.734780838012284,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,17,1.01 [0.97-1.04],0.740443705835131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.05 [0.78-1.42],0.740558071483651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,S100P,Protein S100-P,Inverse variance weighted,2,0.96 [0.73-1.25],0.741371425270197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADAMTSL5,ADAMTS-like protein 5,Inverse variance weighted,15,0.99 [0.96-1.03],0.743316893022596,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1.02 [0.92-1.12],0.743965351418578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.99 [0.96-1.03],0.744374059812824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,P4HB,Protein disulfide-isomerase,Inverse variance weighted,2,1.04 [0.81-1.33],0.745897976938899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.99 [0.92-1.06],0.746098678500998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL17,C-C motif chemokine 17,Inverse variance weighted,9,0.99 [0.93-1.05],0.747124955079266,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,8,1.02 [0.91-1.14],0.751357421654623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.02 [0.91-1.13],0.751579589983362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GRP,Gastrin-releasing peptide,Inverse variance weighted,12,1.01 [0.97-1.04],0.751765957412929,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.01 [0.94-1.09],0.754589774768369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,1.04 [0.82-1.31],0.755036023052894,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.01 [0.94-1.1],0.755421631411773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.01 [0.97-1.05],0.764092738718524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,0.98 [0.85-1.13],0.764944844908338,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,16,0.99 [0.96-1.03],0.767213081620772,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCG3,Secretogranin-3,Inverse variance weighted,32,1 [0.97-1.04],0.768019775353185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.97 [0.8-1.18],0.768792992510565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,6,0.99 [0.91-1.07],0.770914757715845,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MMP7,Matrilysin,Inverse variance weighted,13,1.01 [0.96-1.05],0.772576843673297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD276,CD276 antigen,Inverse variance weighted,20,1 [0.97-1.03],0.77282111599525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SPON1,Spondin-1,Inverse variance weighted,21,0.99 [0.95-1.04],0.773610133725157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,1.01 [0.96-1.06],0.773800476983021,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACE,Angiotensin-converting enzyme,Inverse variance weighted,26,1 [0.97-1.04],0.774950061081694,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AFM,Afamin,Inverse variance weighted,5,1.03 [0.86-1.23],0.775423331404904,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,0.99 [0.96-1.03],0.778026787387996,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,25,1.01 [0.97-1.05],0.778566745822857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD36,Platelet glycoprotein 4,Inverse variance weighted,5,0.99 [0.95-1.04],0.779399942998593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.01 [0.96-1.06],0.780400791623642,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1.01 [0.94-1.09],0.782436097044663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Wald ratio,1,0.97 [0.79-1.19],0.783319781786394,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FIS1,Mitochondrial fission 1 protein,Wald ratio,1,1.01 [0.92-1.12],0.784080109463596,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CTSS,Cathepsin S,Inverse variance weighted,23,1 [0.97-1.04],0.785892696882368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.01 [0.94-1.08],0.789976787471401,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,INHBC,Inhibin beta C chain,Inverse variance weighted,29,1 [0.98-1.03],0.794978669086474,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RBP2,Retinol-binding protein 2,Wald ratio,1,1.04 [0.8-1.34],0.795720546531893,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DKK1,Dickkopf-related protein 1,Inverse variance weighted,4,0.99 [0.88-1.1],0.795880336511126,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SARG,Specifically androgen-regulated gene protein,Wald ratio,1,0.97 [0.78-1.21],0.801622798112026,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PRSS2,Trypsin-2,Inverse variance weighted,3,0.97 [0.78-1.21],0.803057465513904,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1 [0.96-1.03],0.803106784442096,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NPPC,C-type natriuretic peptide,Wald ratio,1,0.95 [0.65-1.4],0.804873287313759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1.02 [0.86-1.22],0.805381126287713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.05 [0.73-1.49],0.806060253166828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.01 [0.94-1.09],0.807944370798209,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SEPTIN8,Septin-8,Inverse variance weighted,2,0.99 [0.88-1.1],0.808057232038993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1 [0.98-1.02],0.808558993583485,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.01 [0.96-1.06],0.80964142035687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TDRKH,Tudor and KH domain-containing protein,Inverse variance weighted,8,1.01 [0.91-1.13],0.810757939000234,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,0.99 [0.89-1.09],0.812398971569483,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL17RB,Interleukin-17 receptor B,Inverse variance weighted,36,1 [0.98-1.03],0.813266710739657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APOA2,Apolipoprotein A-II,Wald ratio,1,0.97 [0.76-1.24],0.818750784865042,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TOP2B,DNA topoisomerase 2-beta,Wald ratio,1,0.98 [0.8-1.19],0.81891276915322,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,1 [0.97-1.04],0.821038052591657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NOMO1,Nodal modulator 1,Inverse variance weighted,2,1.01 [0.92-1.12],0.821523287008673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.99 [0.93-1.06],0.824625616449061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,0.99 [0.95-1.04],0.825193843166389,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL5,C-C motif chemokine 5,Inverse variance weighted,2,0.99 [0.9-1.08],0.826034831754379,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,21,1 [0.96-1.04],0.826153507633068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.99 [0.93-1.06],0.827113269327795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,UMOD,Uromodulin,Inverse variance weighted,29,1 [0.98-1.03],0.828418404490358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLEKHO1,Pleckstrin homology domain-containing family O member 1,Inverse variance weighted,2,0.98 [0.82-1.17],0.830328796365276,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1 [0.96-1.05],0.831596704588899,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CHAD,Chondroadherin,Inverse variance weighted,3,1.01 [0.96-1.06],0.831968455124028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,1.02 [0.87-1.18],0.833003255241477,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.99 [0.95-1.05],0.833449894585495,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPINE1,Plasminogen activator inhibitor 1,Inverse variance weighted,4,0.97 [0.76-1.25],0.834092318257368,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CST3,Cystatin-C,Inverse variance weighted,10,0.99 [0.95-1.04],0.834557064466851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,7,1.01 [0.96-1.06],0.836150499467366,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APCS,Serum amyloid P-component,Inverse variance weighted,4,0.99 [0.93-1.06],0.836666452247895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MBL2,Mannose-binding protein C,Inverse variance weighted,40,1 [0.98-1.03],0.837881600091558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.98 [0.85-1.15],0.842570009439034,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.96 [0.66-1.4],0.842810293797866,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DDT,D-dopachrome decarboxylase,Inverse variance weighted,2,0.99 [0.88-1.11],0.843009719799293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GOT1,"Aspartate aminotransferase, cytoplasmic",Wald ratio,1,0.96 [0.65-1.42],0.84373084486638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,YES1,Tyrosine-protein kinase Yes,Inverse variance weighted,2,1.02 [0.82-1.28],0.846803752455041,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BCHE,Cholinesterase,Inverse variance weighted,30,1 [0.96-1.03],0.847564724352161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CDHR2,Cadherin-related family member 2,Inverse variance weighted,2,0.98 [0.83-1.17],0.849215088941573,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CDKN1A,Cyclin-dependent kinase inhibitor 1,Inverse variance weighted,3,1.01 [0.91-1.12],0.849426489359522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,2,0.98 [0.82-1.18],0.850242337056789,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1 [0.96-1.05],0.853272223575214,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.99 [0.94-1.05],0.857474687244932,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EZR,Ezrin,Wald ratio,1,0.97 [0.73-1.31],0.858064666558521,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,16,1 [0.96-1.03],0.858721084832141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APOL1,Apolipoprotein L1,Inverse variance weighted,3,1.01 [0.93-1.09],0.860419461343218,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.98 [0.82-1.18],0.864138592569825,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,1.01 [0.94-1.08],0.864245980618018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,1 [0.97-1.04],0.866218614278172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,1.01 [0.92-1.11],0.866894961145139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,0.96 [0.6-1.53],0.868086715928083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,0.99 [0.86-1.13],0.868267586647039,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.01 [0.94-1.08],0.869043522906153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1 [0.96-1.03],0.869517428041349,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCN2,CCN family member 2,Inverse variance weighted,9,1 [0.95-1.07],0.8718779595171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Wald ratio,1,1.03 [0.75-1.41],0.871914290326104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADA,Adenosine deaminase,Inverse variance weighted,22,1 [0.98-1.03],0.874744659839701,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DNAJC6,Putative tyrosine-protein phosphatase auxilin,Inverse variance weighted,2,0.99 [0.83-1.18],0.878010891576666,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,2,1.01 [0.85-1.22],0.878058534620241,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PSAP,Prosaposin,Inverse variance weighted,5,1.01 [0.9-1.14],0.878605621604118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MCAM,Cell surface glycoprotein MUC18,Wald ratio,1,0.99 [0.88-1.12],0.881306735003351,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SIAE,Sialate O-acetylesterase,Inverse variance weighted,3,1.01 [0.94-1.08],0.883310762911502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD46,Membrane cofactor protein,Wald ratio,1,0.99 [0.83-1.18],0.887444997141499,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1 [0.96-1.03],0.887728715033104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HMOX1,Heme oxygenase 1,Wald ratio,1,1.02 [0.8-1.29],0.888702246072766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.96 [0.58-1.6],0.888722421438924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KLK4,Kallikrein-4,Inverse variance weighted,17,1 [0.96-1.04],0.89017726846697,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DSG2,Desmoglein-2,Inverse variance weighted,11,1.01 [0.93-1.08],0.890496320754396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.98 [0.74-1.3],0.892170032147345,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTN,Pleiotrophin,Inverse variance weighted,4,0.99 [0.85-1.15],0.892324299757417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,Inverse variance weighted,2,0.99 [0.79-1.22],0.893971564607096,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1 [0.94-1.07],0.895211950659949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,12,1 [0.97-1.04],0.895471753386948,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CALB1,Calbindin,Inverse variance weighted,2,0.99 [0.82-1.19],0.898069915400581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.99 [0.9-1.09],0.899867362753287,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C9,Complement component C9,Inverse variance weighted,5,0.99 [0.86-1.14],0.901713938148951,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,Inverse variance weighted,14,1 [0.96-1.05],0.903290921516852,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LIPF,Gastric triacylglycerol lipase,Inverse variance weighted,18,1 [0.95-1.05],0.910857823162226,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,Inverse variance weighted,10,1 [0.94-1.05],0.911065909396722,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.98 [0.63-1.51],0.915430793860708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SELP,P-selectin,Inverse variance weighted,8,1 [0.95-1.06],0.916100493292448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,1 [0.97-1.04],0.917605203035009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,2,1.01 [0.88-1.15],0.919217651903861,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OGN,Mimecan,Inverse variance weighted,30,1 [0.97-1.03],0.91958693802118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.01 [0.89-1.13],0.920073622703458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AGRP,Agouti-related protein,Inverse variance weighted,3,0.98 [0.69-1.39],0.922313734058915,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MENT,Protein MENT,Inverse variance weighted,3,1 [0.95-1.06],0.923014953087747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1 [0.95-1.05],0.923257534046669,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FTCD,Formimidoyltransferase-cyclodeaminase,Inverse variance weighted,5,0.99 [0.89-1.11],0.924201212203811,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EGFLAM,Pikachurin,Inverse variance weighted,19,1 [0.97-1.03],0.925307988552555,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,4,0.99 [0.88-1.13],0.927159849476224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,REN,Renin,Inverse variance weighted,4,1 [0.93-1.08],0.930664325461002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD160,CD160 antigen,Inverse variance weighted,11,1 [0.96-1.04],0.931294972561405,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GUCA2A,Guanylin,Inverse variance weighted,9,1 [0.91-1.1],0.934611969432527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,1 [0.91-1.09],0.936963121235616,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LPL,Lipoprotein lipase,Inverse variance weighted,14,1 [0.91-1.09],0.939912557853099,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CALCA,Calcitonin,Inverse variance weighted,5,1.01 [0.81-1.25],0.94070133265605,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.01 [0.85-1.19],0.940729133294677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1 [0.94-1.06],0.941230752932052,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1 [0.9-1.12],0.941840227562915,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD59,CD59 glycoprotein,Inverse variance weighted,4,1 [0.94-1.06],0.942988770055146,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC1B,C-type lectin domain family 1 member B,Inverse variance weighted,2,1 [0.9-1.1],0.944430769055153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CES1,Liver carboxylesterase 1,Inverse variance weighted,15,1 [0.96-1.04],0.945012347366258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1 [0.95-1.06],0.946779769522245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CHMP6,Charged multivesicular body protein 6,Wald ratio,1,1 [0.91-1.09],0.948039301575086,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1 [0.97-1.03],0.948360660257201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1 [0.94-1.06],0.948509933778864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAYN,Layilin,Inverse variance weighted,20,1 [0.96-1.05],0.950780713804636,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,A1BG,Alpha-1B-glycoprotein,Inverse variance weighted,5,1 [0.95-1.06],0.952124663903372,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,1.01 [0.84-1.2],0.952179702265067,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1 [0.88-1.15],0.952666389615221,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C7,Complement component C7,Inverse variance weighted,38,1 [0.98-1.02],0.952760421245491,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLG,Plasminogen,Inverse variance weighted,20,1 [0.92-1.09],0.954172966851749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,1.01 [0.83-1.22],0.954393562267499,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,1 [0.96-1.05],0.955550254094249,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APP,Amyloid-beta precursor protein,Wald ratio,1,0.99 [0.79-1.25],0.957269195797328,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,1.01 [0.64-1.61],0.960102002541015,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAMB1,Laminin subunit beta-1,Inverse variance weighted,35,1 [0.97-1.03],0.960862292258135,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,1 [0.98-1.02],0.967985240534965,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EPO,Erythropoietin,Inverse variance weighted,5,1 [0.83-1.21],0.971100193962488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Inverse variance weighted,6,1 [0.91-1.1],0.971157462830279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD63,CD63 antigen,Wald ratio,1,1.01 [0.68-1.5],0.972360486717117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GLO1,Lactoylglutathione lyase,Inverse variance weighted,13,1 [0.95-1.05],0.977071217957556,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LGALS3,Galectin-3,Inverse variance weighted,25,1 [0.97-1.03],0.977685720043771,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1 [0.88-1.15],0.978715879350908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,5,1 [0.9-1.11],0.980778041885069,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PRG2,Bone marrow proteoglycan,Wald ratio,1,1 [0.82-1.23],0.98176903590093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1 [0.96-1.04],0.982053891083789,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CDH1,Cadherin-1,Wald ratio,1,1 [0.71-1.41],0.982568329643674,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1 [0.95-1.05],0.982690697623541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,1 [0.96-1.04],0.983419179309622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CYB5R2,NADH-cytochrome b5 reductase 2,Inverse variance weighted,14,1 [0.97-1.04],0.983966586719081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1 [0.87-1.14],0.985629150261038,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GPD1,Glycerol-3-phosphate dehydrogenase,Wald ratio,1,1 [0.77-1.29],0.988389438627946,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPINB8,Serpin B8,Inverse variance weighted,28,1 [0.98-1.02],0.990036386166384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LGALS1,Galectin-1,Inverse variance weighted,6,1 [0.95-1.05],0.990655117449198,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HEG1,Protein HEG homolog 1,Inverse variance weighted,4,1 [0.88-1.14],0.992719838775599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLIP2,CAP-Gly domain-containing linker protein 2,Inverse variance weighted,2,1 [0.89-1.12],0.993097779370142,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1 [0.65-1.54],0.993127671526289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANXA2,Annexin A2,Inverse variance weighted,20,1 [0.97-1.04],0.994296482871375,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,1 [0.91-1.1],0.998907451932569,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FUOM,Fucose mutarotase,Inverse variance weighted,3,1 [0.87-1.15],0.999376592468649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,4.98 [3.55-6.99],1.50060462123279e-20,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SNCA,Alpha-synuclein,Wald ratio,1,5.21 [3.68-7.38],1.50060462123279e-20,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,4.34 [2.92-6.44],3.71752895130483e-13,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GRN,Progranulin,Inverse variance weighted,46,1.12 [1.07-1.17],3.5581252948768e-07,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GSTA1,Glutathione S-transferase A1,Wald ratio,1,0.39 [0.26-0.57],1.53338539754471e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LGALS4,Galectin-4,Inverse variance weighted,15,0.91 [0.87-0.95],3.26335936113396e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SNAP25,Synaptosomal-associated protein 25,Inverse variance weighted,13,1.25 [1.14-1.39],7.49160033410146e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,2.02 [1.44-2.84],5.51802596816786e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,Inverse variance weighted,11,1.18 [1.08-1.29],0.000158960517940617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IDUA,Alpha-L-iduronidase,Inverse variance weighted,18,1.41 [1.18-1.69],0.000192098198252822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,Inverse variance weighted,20,1.16 [1.07-1.26],0.000458945841786624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,F2,Prothrombin,Inverse variance weighted,18,1.11 [1.05-1.19],0.000680360944330773,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,1.07 [1.03-1.11],0.000925681448884972,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C9,Complement component C9,Inverse variance weighted,7,0.68 [0.54-0.85],0.000928858138039663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Inverse variance weighted,6,0.75 [0.63-0.89],0.00126900229459186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KITLG,Kit ligand,Inverse variance weighted,30,1.14 [1.05-1.24],0.00147112054252578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MYH9,Myosin-9,Inverse variance weighted,3,0.74 [0.62-0.89],0.0017270074986959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APOL1,Apolipoprotein L1,Inverse variance weighted,46,0.95 [0.92-0.98],0.00194821923649777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MPO,Myeloperoxidase,Inverse variance weighted,17,1.07 [1.02-1.11],0.00242681921684364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,5,0.47 [0.29-0.77],0.00284834470039407,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,F12,Coagulation factor XII,Inverse variance weighted,17,1.11 [1.04-1.19],0.00304320102284249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CPB2,Carboxypeptidase B2,Inverse variance weighted,4,1.51 [1.15-1.99],0.00305017584360455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,11,1.1 [1.03-1.17],0.00306508157706808,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FIS1,Mitochondrial fission 1 protein,Inverse variance weighted,3,0.71 [0.57-0.9],0.00354523268058456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.18 [1.06-1.33],0.00392757300399129,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TDRKH,Tudor and KH domain-containing protein,Wald ratio,1,0.57 [0.39-0.84],0.00416072061307343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SNAP29,Synaptosomal-associated protein 29,Wald ratio,1,0.6 [0.42-0.85],0.00416072061307343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.96 [0.93-0.99],0.00427419942114876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,25,0.86 [0.78-0.96],0.00438872842517452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SPON1,Spondin-1,Inverse variance weighted,4,1.26 [1.07-1.48],0.00570582454185027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.05 [1.01-1.09],0.00603909891534949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,1.05 [1.01-1.08],0.00680108381282432,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CPE,Carboxypeptidase E,Inverse variance weighted,10,0.83 [0.73-0.95],0.00680652677718015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,2.44 [1.27-4.66],0.00707366626221887,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPING1,Plasma protease C1 inhibitor,Inverse variance weighted,21,1.14 [1.03-1.26],0.00870534184575338,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.19 [1.04-1.35],0.00894823904547579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGSF9,Protein turtle homolog A,Inverse variance weighted,2,1.44 [1.09-1.9],0.00944468099499708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.66 [1.13-2.44],0.0105110800147168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.89 [0.81-0.97],0.0106957451317232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KYNU,Kynureninase,Inverse variance weighted,3,1.78 [1.14-2.77],0.0110241687240133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CETN2,Centrin-2,Wald ratio,1,0.66 [0.47-0.91],0.0127254755839381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL6,Interleukin-6,Inverse variance weighted,6,0.92 [0.86-0.98],0.0129987160953304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APCS,Serum amyloid P-component,Inverse variance weighted,3,1.28 [1.05-1.56],0.0131305764822952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,12,0.82 [0.7-0.96],0.013554124219478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,17,0.91 [0.84-0.98],0.014079813323183,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.77 [0.63-0.95],0.014454784748523,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TTR,Transthyretin,Inverse variance weighted,11,0.83 [0.71-0.96],0.0150414015257033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPINA4,Kallistatin,Inverse variance weighted,7,1.46 [1.08-2],0.0154802502703955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCN1,CCN family member 1,Inverse variance weighted,6,1.65 [1.1-2.48],0.0157031919855026,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NRP2,Neuropilin-2,Inverse variance weighted,14,1.15 [1.03-1.3],0.0160611353898774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,17,1.1 [1.02-1.2],0.0175761840293192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LDLR,Low-density lipoprotein receptor,Inverse variance weighted,17,1.28 [1.04-1.57],0.0184669902676744,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ARF6,ADP-ribosylation factor 6,Wald ratio,1,0.65 [0.45-0.93],0.0192065601543006,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.3 [1.04-1.62],0.021114920125935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.16 [1.02-1.32],0.0211666379999439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.1 [1.01-1.19],0.0214824672352495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.14 [1.02-1.27],0.0220011943616868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLG,Plasminogen,Inverse variance weighted,6,1.33 [1.04-1.71],0.0241563728299675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GFRAL,GDNF family receptor alpha-like,Inverse variance weighted,25,0.94 [0.89-0.99],0.0271440555952313,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,0.9 [0.83-0.99],0.0272224203317291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.96 [0.92-1],0.0281721060029277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VWC2,Brorin,Inverse variance weighted,12,1.15 [1.01-1.31],0.0287846108516884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LPL,Lipoprotein lipase,Inverse variance weighted,8,0.61 [0.39-0.95],0.0294158626949443,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EZR,Ezrin,Wald ratio,1,0.69 [0.5-0.96],0.0297221003409333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EGLN1,Egl nine homolog 1,Wald ratio,1,0.66 [0.46-0.96],0.0299897773634846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.06 [1.01-1.13],0.0303228492698103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,6,0.9 [0.82-0.99],0.0304037960213995,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.13 [1.01-1.25],0.0322451580256176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KLB,Beta-klotho,Inverse variance weighted,23,1.09 [1.01-1.18],0.0323819019898595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.88 [0.79-0.99],0.032602245731517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KLK11,Kallikrein-11,Inverse variance weighted,13,1.09 [1.01-1.18],0.0329613671424591,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCN3,CCN family member 3,Inverse variance weighted,17,1.05 [1-1.11],0.0345869866155607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.91 [0.84-0.99],0.0349534858122765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,F7,Coagulation factor VII,Inverse variance weighted,10,1.14 [1.01-1.29],0.0350635745586325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HHEX,Hematopoietically-expressed homeobox protein HHEX,Wald ratio,1,0.66 [0.44-0.97],0.0351251801573957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.17 [1.01-1.36],0.0368576099839203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MMP7,Matrilysin,Wald ratio,1,0.86 [0.74-0.99],0.0377379727104951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HTRA2,"Serine protease HTRA2, mitochondrial",Wald ratio,1,1.43 [1.02-2],0.0379350392831292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.14 [1.01-1.28],0.038352598487149,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.42 [1.02-1.99],0.0384498993833869,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.36 [1.02-1.82],0.0387844878593777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.96 [0.92-1],0.0388664052771527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.86 [1.03-3.35],0.0393459317251166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.75 [1.03-2.98],0.0402122766884904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MOCS2,Molybdopterin synthase catalytic subunit,Inverse variance weighted,5,1.15 [1-1.33],0.0426170296015884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.07 [1-1.14],0.0446327962674369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,6,0.77 [0.6-0.99],0.0447197488379154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,Inverse variance weighted,48,0.96 [0.92-1],0.0457080083566456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.18 [1-1.38],0.048248147118748,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXCL6,C-X-C motif chemokine 6,Inverse variance weighted,9,0.75 [0.57-1],0.0483826353732429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.05 [1-1.1],0.049934729892423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.7 [0.48-1],0.0505203636329363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,Inverse variance weighted,4,0.85 [0.72-1],0.0511556403052611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.18 [1-1.39],0.0523190430430588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PPL,Periplakin,Inverse variance weighted,2,1.4 [1-1.98],0.0530265535608327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DNAJC6,Putative tyrosine-protein phosphatase auxilin,Inverse variance weighted,5,0.89 [0.79-1],0.0541514199737502,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.16 [1-1.35],0.0542218508222205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.42 [0.99-2.04],0.0546036970923648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.78 [0.6-1.01],0.0559654461538478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OGA,Protein O-GlcNAcase,Inverse variance weighted,2,0.89 [0.79-1],0.0573511238142977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,0.74 [0.55-1.01],0.0584101976634382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CDH5,Cadherin-5,Inverse variance weighted,23,0.97 [0.94-1],0.0600466029250945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.92 [0.84-1],0.0605961001300957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,1.02 [1-1.04],0.0616429144180213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DGKA,Diacylglycerol kinase alpha,Wald ratio,1,0.7 [0.49-1.02],0.0620585575831481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.11 [0.99-1.24],0.06257904818416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,1.18 [0.99-1.41],0.0635522522319969,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANG,Angiogenin,Inverse variance weighted,9,1.26 [0.99-1.6],0.0652637162233862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CST3,Cystatin-C,Inverse variance weighted,3,1.22 [0.99-1.51],0.0674851364864829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.86 [0.73-1.01],0.0693105640616008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CTSB,Cathepsin B,Inverse variance weighted,28,0.93 [0.87-1.01],0.0693232518791505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAYN,Layilin,Inverse variance weighted,3,1.22 [0.98-1.53],0.0701873041991498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.12 [0.99-1.26],0.0707077544932634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SMAD5,Mothers against decapentaplegic homolog 5,Inverse variance weighted,8,0.94 [0.88-1.01],0.072144795503065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COL2A1,Collagen alpha-1(II) chain,Inverse variance weighted,30,0.95 [0.91-1],0.0726314989513997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.65 [0.41-1.04],0.0726673391183033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",Wald ratio,1,0.72 [0.5-1.03],0.0732955727446696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AGRP,Agouti-related protein,Inverse variance weighted,16,1.19 [0.98-1.44],0.0746371728788772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MARCO,Macrophage receptor MARCO,Inverse variance weighted,27,1.07 [0.99-1.14],0.0747002685574988,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MFGE8,Lactadherin,Inverse variance weighted,15,1.27 [0.98-1.66],0.0755886846333483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,5,1.13 [0.99-1.29],0.0763814372247821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCN4,CCN family member 4,Inverse variance weighted,29,1.04 [1-1.08],0.0770712830086578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.15 [0.98-1.34],0.0782073731811027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.97 [0.93-1],0.0789633249328604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.26 [0.97-1.62],0.0807925802148071,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,50,1.06 [0.99-1.14],0.0814218961378245,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD83,CD83 antigen,Inverse variance weighted,14,0.89 [0.79-1.01],0.0815979226120878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PBLD,Phenazine biosynthesis-like domain-containing protein,Inverse variance weighted,22,1.03 [1-1.07],0.0839983705062998,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.96 [0.92-1.01],0.0856746083257978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFSF14,Tumor necrosis factor ligand superfamily member 14,Inverse variance weighted,3,1.18 [0.98-1.42],0.0863530003769926,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,0.87 [0.74-1.02],0.0868849917456044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APOE,Apolipoprotein E,Inverse variance weighted,6,1.3 [0.96-1.75],0.0874337395092252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.24 [0.97-1.6],0.0877465923446566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MENT,Protein MENT,Inverse variance weighted,28,1.1 [0.99-1.24],0.0881769076182191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.13 [0.98-1.29],0.0885102702766277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FBLN2,Fibulin-2,Inverse variance weighted,6,1.21 [0.97-1.5],0.0930886315550602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PGA4,Pepsin A-4,Inverse variance weighted,7,0.87 [0.73-1.02],0.0936232967619285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.07 [0.99-1.17],0.0963042146423838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPINH1,Serpin H1,Inverse variance weighted,5,0.9 [0.79-1.02],0.0971787965637511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CTSL,Cathepsin L1,Inverse variance weighted,29,1.06 [0.99-1.13],0.0999460558146015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,22,1.06 [0.99-1.14],0.104413207616921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.94 [0.86-1.01],0.10656022671274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NID1,Nidogen-1,Inverse variance weighted,6,1.09 [0.98-1.22],0.106684553292165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ITGA5,Integrin alpha-5,Inverse variance weighted,18,1.07 [0.99-1.15],0.106740341633108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ROBO2,Roundabout homolog 2,Inverse variance weighted,6,1.11 [0.98-1.27],0.107283228320958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.28 [0.95-1.72],0.109205058127955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.75 [0.53-1.07],0.110870416730542,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.11 [0.98-1.25],0.114099811673327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.16 [0.96-1.4],0.117523884530137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SELE,E-selectin,Inverse variance weighted,20,0.92 [0.83-1.02],0.120017569583027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.11 [0.97-1.27],0.120238221295495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.32 [0.93-1.88],0.122053692391179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.84 [0.68-1.05],0.122121731035292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NPY,Pro-neuropeptide Y,Inverse variance weighted,15,1.18 [0.96-1.45],0.122204509997137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.17 [0.96-1.43],0.12303511325715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MMP1,Interstitial collagenase,Inverse variance weighted,14,0.94 [0.87-1.02],0.124139865284933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",Inverse variance weighted,4,1.16 [0.96-1.39],0.124536637195553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,0.97 [0.93-1.01],0.125103761153337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,32,0.94 [0.87-1.02],0.12798715613769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADIPOQ,Adiponectin,Inverse variance weighted,25,0.94 [0.86-1.02],0.131738580486226,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.29 [0.93-1.81],0.131961949303627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD27,CD27 antigen,Inverse variance weighted,9,0.85 [0.7-1.05],0.132423922505758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPINF2,Alpha-2-antiplasmin,Inverse variance weighted,3,1.56 [0.87-2.81],0.134348099403859,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FETUB,Fetuin-B,Inverse variance weighted,5,1.27 [0.93-1.72],0.134721163622885,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AGR3,Anterior gradient protein 3,Inverse variance weighted,5,1.33 [0.92-1.92],0.134751205521602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,12,0.82 [0.62-1.07],0.136480084698955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.9 [0.79-1.03],0.136513251053065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APOD,Apolipoprotein D,Inverse variance weighted,9,0.64 [0.36-1.15],0.139170612508218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,14,0.87 [0.73-1.05],0.140886615647396,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.21 [0.94-1.55],0.141246782817648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,1.43 [0.89-2.31],0.141521251127974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,14,1.09 [0.97-1.22],0.142008560373222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BCAN,Brevican core protein,Inverse variance weighted,12,1.09 [0.97-1.22],0.142171217875832,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.98 [0.95-1.01],0.142236278135243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.97 [0.93-1.01],0.142832902508517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.94 [0.86-1.02],0.14386674912524,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BCHE,Cholinesterase,Inverse variance weighted,38,1.03 [0.99-1.08],0.144265644769632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NFASC,Neurofascin,Inverse variance weighted,6,0.73 [0.48-1.11],0.145280018573939,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,1.19 [0.94-1.5],0.146245171192475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.1 [0.96-1.27],0.148749106052274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,0.88 [0.74-1.05],0.150268458229644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,Inverse variance weighted,4,0.88 [0.75-1.05],0.150693231148796,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MTSS1,Protein MTSS 1,Wald ratio,1,1.27 [0.92-1.75],0.153548815747569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,0.77 [0.54-1.1],0.15365302968921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.25 [0.92-1.71],0.153948959075337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CFI,Complement factor I,Wald ratio,1,0.71 [0.44-1.14],0.15400496044853,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TP53I3,Quinone oxidoreductase PIG3,Inverse variance weighted,4,0.93 [0.84-1.03],0.15474313801878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,21,0.92 [0.82-1.03],0.155118866590845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DDT,D-dopachrome decarboxylase,Wald ratio,1,1.31 [0.9-1.9],0.157117617603734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.84 [0.66-1.07],0.157497989778491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CYB5R2,NADH-cytochrome b5 reductase 2,Inverse variance weighted,2,1.21 [0.93-1.58],0.157670698795673,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PRSS2,Trypsin-2,Inverse variance weighted,17,0.92 [0.83-1.03],0.158744038278151,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.95 [0.89-1.02],0.159249139487369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CES1,Liver carboxylesterase 1,Inverse variance weighted,19,0.91 [0.79-1.04],0.159358965928069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.26 [0.91-1.74],0.159997032320746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HEPACAM2,HEPACAM family member 2,Inverse variance weighted,69,0.98 [0.95-1.01],0.160552266871484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,4,0.89 [0.76-1.05],0.162112988650497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.85 [0.68-1.07],0.166360184206475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HEPH,Hephaestin,Inverse variance weighted,6,0.93 [0.84-1.03],0.166632204808653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,0.92 [0.81-1.04],0.166764245394506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.98 [0.96-1.01],0.166907088552916,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.52 [0.84-2.77],0.167778259507433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.93 [0.84-1.03],0.167826046818416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,5,0.76 [0.52-1.12],0.168677022680793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LCAT,Phosphatidylcholine-sterol acyltransferase,Inverse variance weighted,11,1.23 [0.91-1.67],0.168893579530907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OPLAH,5-oxoprolinase,Inverse variance weighted,3,0.82 [0.61-1.09],0.169355471218805,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Wald ratio,1,1.18 [0.93-1.48],0.170176270538653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.07 [0.97-1.19],0.17460261669519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.92 [0.82-1.04],0.178275316356582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,0.96 [0.9-1.02],0.179467210262639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RBPMS2,RNA-binding protein with multiple splicing 2,Wald ratio,1,0.78 [0.54-1.12],0.180274104224906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MSLN,Mesothelin,Inverse variance weighted,11,1.09 [0.96-1.24],0.180422560107147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,XPNPEP2,Xaa-Pro aminopeptidase 2,Inverse variance weighted,20,0.93 [0.83-1.04],0.18221815023841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.14 [0.94-1.38],0.183927981082726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,3,0.84 [0.64-1.09],0.185661502653439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.03 [0.98-1.08],0.185754290872519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DSG3,Desmoglein-3,Inverse variance weighted,27,0.97 [0.92-1.02],0.186439568715229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLIN1,Perilipin-1,Wald ratio,1,0.8 [0.57-1.12],0.187893792409857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,1.05 [0.98-1.12],0.18946547311439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ERBB3,Receptor tyrosine-protein kinase erbB-3,Inverse variance weighted,11,1.06 [0.97-1.17],0.191873905957689,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL17RB,Interleukin-17 receptor B,Inverse variance weighted,23,0.87 [0.7-1.07],0.192577563147617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,1.17 [0.92-1.49],0.193939160832242,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.07 [0.97-1.18],0.195168026638782,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SELP,P-selectin,Inverse variance weighted,4,1.18 [0.92-1.51],0.197253327381225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.05 [0.98-1.13],0.197441264629303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.87 [0.71-1.08],0.199269166507985,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Inverse variance weighted,2,1.34 [0.86-2.1],0.199873502219283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,54,1.01 [0.99-1.04],0.200248180133923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.87 [0.7-1.08],0.200702141944289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC3B,Tetranectin,Inverse variance weighted,2,1.2 [0.9-1.61],0.204796118768061,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,33,1.03 [0.98-1.09],0.206380426145769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.07 [0.97-1.18],0.208910786519733,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.16 [0.92-1.48],0.209864770143554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.93 [0.82-1.04],0.210114671008033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.93 [0.83-1.04],0.210901295161208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GAST,Gastrin,Inverse variance weighted,9,0.93 [0.83-1.04],0.211865846135184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HAO1,Hydroxyacid oxidase 1,Inverse variance weighted,6,0.88 [0.73-1.07],0.212617932542445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.89 [0.73-1.07],0.214537678253647,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GPI,Glucose-6-phosphate isomerase,Wald ratio,1,1.27 [0.87-1.87],0.216281205216374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,13,1.17 [0.91-1.49],0.216683527121932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,7,1.09 [0.95-1.24],0.219059729162913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.8 [0.56-1.14],0.219497065713059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SHMT1,"Serine hydroxymethyltransferase, cytosolic",Inverse variance weighted,4,1.08 [0.95-1.23],0.220183307565204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,1.04 [0.98-1.11],0.220218138052919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.14 [0.92-1.41],0.220783701386278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DAAM1,Disheveled-associated activator of morphogenesis 1,Inverse variance weighted,4,0.84 [0.64-1.11],0.221962877283541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AGRN,Agrin,Inverse variance weighted,14,1.08 [0.96-1.21],0.222566876286962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.14 [0.92-1.41],0.227784204523411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,11,0.97 [0.92-1.02],0.229245279056321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.03 [0.98-1.09],0.229461071066858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCAMP3,Secretory carrier-associated membrane protein 3,Wald ratio,1,0.85 [0.64-1.11],0.232955877753412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,Inverse variance weighted,4,1.24 [0.87-1.77],0.233887300543071,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,0.95 [0.88-1.03],0.234630158312153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.24 [0.87-1.78],0.235589528664802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.07 [0.96-1.18],0.235771312180009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LGALS3,Galectin-3,Inverse variance weighted,15,1.07 [0.96-1.2],0.236304363955383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NRP1,Neuropilin-1,Inverse variance weighted,14,0.91 [0.77-1.07],0.238931734780378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,QDPR,Dihydropteridine reductase,Wald ratio,1,1.66 [0.71-3.87],0.24049213616043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TIMP3,Metalloproteinase inhibitor 3,Inverse variance weighted,6,0.91 [0.77-1.07],0.241046720102858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AREG,Amphiregulin,Inverse variance weighted,5,1.09 [0.94-1.26],0.241554025418742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.96 [0.89-1.03],0.243031240259752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.11 [0.93-1.34],0.243509039590439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FASLG,Tumor necrosis factor ligand superfamily member 6,Inverse variance weighted,53,1.03 [0.98-1.08],0.244718857437039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.91 [0.78-1.07],0.247251949440955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.2 [0.88-1.62],0.248115252401073,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.93 [0.83-1.05],0.24867579919713,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.85 [0.65-1.12],0.249424387632099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.94 [0.84-1.05],0.250175168782486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C7,Complement component C7,Inverse variance weighted,26,1.02 [0.99-1.05],0.251013764366559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.2 [0.88-1.63],0.255097102402726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HGF,Hepatocyte growth factor,Inverse variance weighted,5,1.15 [0.9-1.46],0.258169166774092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PEBP1,Phosphatidylethanolamine-binding protein 1,Inverse variance weighted,2,0.84 [0.63-1.14],0.259811392309228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,5,1.07 [0.95-1.22],0.263657551095058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTPRF,Receptor-type tyrosine-protein phosphatase F,Inverse variance weighted,17,0.93 [0.82-1.06],0.263846505584093,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,20,1.12 [0.92-1.37],0.264661370496333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.86 [0.65-1.13],0.267348300039336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,STAB2,Stabilin-2,Inverse variance weighted,14,1.08 [0.94-1.24],0.268080188704374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,P4HB,Protein disulfide-isomerase,Inverse variance weighted,4,1.33 [0.8-2.2],0.268747667942031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,17,0.96 [0.9-1.03],0.270745402778577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.06 [0.95-1.19],0.272199875053015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LMNB2,Lamin-B2,Inverse variance weighted,8,1.09 [0.93-1.27],0.273433698374079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.88 [0.69-1.11],0.275494570905617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LGALS9,Galectin-9,Inverse variance weighted,36,0.98 [0.95-1.02],0.276440564075812,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DEFB4A_DEFB4B,Beta-defensin 4A,Inverse variance weighted,7,1.27 [0.82-1.98],0.280442815573202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,0.92 [0.79-1.07],0.280529853413103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,1.09 [0.94-1.26],0.280606101865902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FLT3,Receptor-type tyrosine-protein kinase FLT3,Inverse variance weighted,8,0.89 [0.71-1.1],0.281016625396381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,1.13 [0.91-1.4],0.284003082329698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.24 [0.84-1.83],0.284336872484184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.94 [0.83-1.05],0.285355068381147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,0.94 [0.83-1.06],0.287306405730706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,F11,Coagulation factor XI,Inverse variance weighted,22,1.03 [0.98-1.08],0.289698534698064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.09 [0.93-1.27],0.290458078907652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,1.05 [0.96-1.14],0.29230662691884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.08 [0.94-1.23],0.293752485180486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DSG2,Desmoglein-2,Inverse variance weighted,22,0.93 [0.82-1.06],0.293782010687536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.13 [0.9-1.41],0.295977767532057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.97 [0.91-1.03],0.296875548289276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.05 [0.96-1.16],0.297614307626946,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.06 [0.95-1.19],0.297974237343992,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SORT1,Sortilin,Inverse variance weighted,11,1.18 [0.87-1.6],0.298669015813979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CPM,Carboxypeptidase M,Inverse variance weighted,19,1.11 [0.91-1.35],0.300615769276953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SPP1,Osteopontin,Inverse variance weighted,13,0.92 [0.79-1.07],0.30182508773819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.93 [0.82-1.06],0.302384077881923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PDGFB,Platelet-derived growth factor subunit B,Inverse variance weighted,8,1.08 [0.93-1.26],0.304090634523553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.16 [0.87-1.55],0.304392984791721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD58,Lymphocyte function-associated antigen 3,Inverse variance weighted,6,1.04 [0.96-1.13],0.305648488464933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CTSO,Cathepsin O,Inverse variance weighted,19,0.89 [0.7-1.12],0.305732814336764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CNTN3,Contactin-3,Inverse variance weighted,20,0.92 [0.79-1.08],0.306684034497133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGA,Fibrinogen alpha chain,Inverse variance weighted,6,1.12 [0.9-1.41],0.30920251947556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.7 [0.36-1.39],0.311742134661124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.08 [0.93-1.25],0.31235373711411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Wald ratio,1,0.84 [0.6-1.18],0.31341526716306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,1.02 [0.99-1.05],0.315097839429546,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.22 [0.83-1.8],0.31566491579974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.09 [0.92-1.28],0.316166728466563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.08 [0.93-1.24],0.318393044980328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CDHR2,Cadherin-related family member 2,Inverse variance weighted,13,1.09 [0.92-1.3],0.319157797568369,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CREG1,Protein CREG1,Inverse variance weighted,20,0.97 [0.9-1.03],0.321374169502453,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.08 [0.92-1.27],0.325377462846871,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL19,Interleukin-19,Inverse variance weighted,10,1.04 [0.96-1.12],0.325422803032094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APOA1,Apolipoprotein A-I,Inverse variance weighted,13,0.82 [0.55-1.22],0.32600032994855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FURIN,Furin,Inverse variance weighted,3,0.86 [0.64-1.16],0.327140441048325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC1B,C-type lectin domain family 1 member B,Wald ratio,1,1.18 [0.85-1.62],0.327238579664909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AMBP,Protein AMBP,Inverse variance weighted,5,1.15 [0.87-1.51],0.327637300014581,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.98-1.05],0.32811211167485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BRK1,Protein BRICK1,Inverse variance weighted,10,1.17 [0.85-1.6],0.32867800860823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MAMDC4,Apical endosomal glycoprotein,Inverse variance weighted,6,1.03 [0.97-1.09],0.329262398021904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.1 [0.91-1.32],0.330811675183001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PDLIM7,PDZ and LIM domain protein 7,Wald ratio,1,1.23 [0.81-1.86],0.331024895728688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.25 [0.79-1.98],0.332555520331802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ATOX1,Copper transport protein ATOX1,Wald ratio,1,1.07 [0.93-1.24],0.33282220489409,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.19 [0.84-1.69],0.333438469804421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.94 [0.84-1.06],0.333921766288062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.11 [0.9-1.36],0.334779450584079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SELL,L-selectin,Inverse variance weighted,11,0.94 [0.84-1.06],0.334888885574401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,0.9 [0.73-1.11],0.336723600762637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CA6,Carbonic anhydrase 6,Inverse variance weighted,20,0.93 [0.79-1.08],0.337125139681902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,Wald ratio,1,1.24 [0.8-1.92],0.337199068565148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EHBP1,EH domain-binding protein 1,Inverse variance weighted,4,0.85 [0.61-1.18],0.337596421893918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,15,0.92 [0.79-1.09],0.339405978319216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.07 [0.93-1.22],0.33941866681727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PALM2,Paralemmin-2,Inverse variance weighted,9,1.03 [0.97-1.1],0.339676870265155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LATS1,Serine/threonine-protein kinase LATS1,Inverse variance weighted,4,0.89 [0.71-1.13],0.341573342470618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OMD,Osteomodulin,Inverse variance weighted,15,1.04 [0.96-1.12],0.344754477576621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,40,0.98 [0.94-1.02],0.344780432362403,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PAMR1,Inactive serine protease PAMR1,Inverse variance weighted,6,1.2 [0.82-1.76],0.344849131525247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FABP6,Gastrotropin,Inverse variance weighted,4,0.92 [0.77-1.1],0.345481857621557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,1.05 [0.95-1.16],0.346470469847378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C19orf12,Protein C19orf12,Inverse variance weighted,3,0.9 [0.71-1.13],0.34829226619177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCN2,CCN family member 2,Inverse variance weighted,15,1.13 [0.87-1.47],0.349134860162578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,5,1.08 [0.92-1.28],0.350857580074048,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VPS53,Vacuolar protein sorting-associated protein 53 homolog,Inverse variance weighted,2,0.88 [0.67-1.15],0.351435850066768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LGALS8,Galectin-8,Inverse variance weighted,8,0.89 [0.69-1.14],0.352047232640875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,0.93 [0.79-1.09],0.355792938672718,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.08 [0.91-1.29],0.356058136097627,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.89 [0.71-1.13],0.358825515625773,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.93 [0.8-1.08],0.358940007359616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.95 [0.86-1.06],0.361923695485527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,0.89 [0.7-1.14],0.363282063118266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,Wald ratio,1,1.3 [0.73-2.3],0.368349692310957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KHK,Ketohexokinase,Inverse variance weighted,4,0.89 [0.69-1.15],0.368436083532591,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL19,C-C motif chemokine 19,Inverse variance weighted,4,1.14 [0.86-1.52],0.369217156619754,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.85 [0.59-1.22],0.370638912690853,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DAG1,Dystroglycan,Wald ratio,1,1.19 [0.81-1.75],0.371930811404821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TRIAP1,TP53-regulated inhibitor of apoptosis 1,Inverse variance weighted,9,1.05 [0.94-1.17],0.37426720038229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.86 [0.62-1.2],0.374635994938421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD209,CD209 antigen,Inverse variance weighted,34,0.98 [0.94-1.02],0.376924179670119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EPO,Erythropoietin,Inverse variance weighted,11,0.95 [0.86-1.06],0.378515433381119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL17,C-C motif chemokine 17,Inverse variance weighted,27,0.98 [0.94-1.02],0.379103980977109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.31 [0.72-2.38],0.380550564688117,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C3,Complement C3,Inverse variance weighted,2,1.07 [0.92-1.26],0.381290117406385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CFD,Complement factor D,Wald ratio,1,0.86 [0.62-1.2],0.381499232783595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD34,Hematopoietic progenitor cell antigen CD34,Inverse variance weighted,2,1.18 [0.81-1.73],0.382027496965687,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.13 [0.86-1.48],0.384333141007787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.79 [0.47-1.34],0.384772578352928,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.05 [0.95-1.16],0.3860986609168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.06 [0.92-1.22],0.38750509059771,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.1 [0.88-1.37],0.389578386428215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FCN1,Ficolin-1,Inverse variance weighted,50,0.99 [0.95-1.02],0.389803238417841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,0.96 [0.87-1.06],0.392286652172092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PPP1R2,Protein phosphatase inhibitor 2,Wald ratio,1,0.86 [0.6-1.22],0.39263001169446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SPRR3,Small proline-rich protein 3,Inverse variance weighted,6,1.05 [0.93-1.19],0.393774952309513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HPSE,Heparanase,Inverse variance weighted,7,0.94 [0.81-1.09],0.393875156359852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,F11R,Junctional adhesion molecule A,Inverse variance weighted,3,0.85 [0.59-1.23],0.396358278901062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,0.93 [0.79-1.1],0.400082956816909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CDKN1A,Cyclin-dependent kinase inhibitor 1,Inverse variance weighted,2,0.9 [0.7-1.15],0.401278810233345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,35,0.97 [0.9-1.04],0.404019732144005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,XG,Glycoprotein Xg,Inverse variance weighted,2,0.89 [0.68-1.17],0.404107565367136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.03 [0.95-1.12],0.406432414737278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL11,Eotaxin,Inverse variance weighted,11,1.03 [0.96-1.1],0.407398149915938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.19 [0.79-1.79],0.40867806945315,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.03 [0.96-1.11],0.410758385427986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CPB1,Carboxypeptidase B,Inverse variance weighted,18,1.03 [0.96-1.1],0.411180950277966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,0.88 [0.66-1.19],0.411432650872606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.3 [0.69-2.43],0.415011572034861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.07 [0.91-1.27],0.415388957043656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.1 [0.88-1.36],0.415699137086358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.92 [0.76-1.12],0.416822094627607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CNTN5,Contactin-5,Inverse variance weighted,22,0.97 [0.9-1.04],0.418634794444582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CAPG,Macrophage-capping protein,Wald ratio,1,1.13 [0.84-1.52],0.419398003769895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NCAM2,Neural cell adhesion molecule 2,Inverse variance weighted,39,0.99 [0.97-1.01],0.421001331291616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KLK14,Kallikrein-14,Inverse variance weighted,15,1.05 [0.94-1.17],0.422289895472441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.22 [0.75-1.97],0.423268309345787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.06 [0.92-1.22],0.424248573763693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.94 [0.81-1.09],0.426584989878057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.83 [0.53-1.31],0.42794204308266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,4,1.38 [0.62-3.06],0.430567879268107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.94 [0.82-1.09],0.43471360615891,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,1.01 [0.98-1.05],0.436067738769752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNN,Tenascin-N,Inverse variance weighted,41,1.01 [0.98-1.05],0.438791252343515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NIT2,Omega-amidase NIT2,Inverse variance weighted,2,0.86 [0.59-1.26],0.440142888950935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,0.9 [0.69-1.18],0.440414618711813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.11 [0.85-1.45],0.441113307385758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL5,C-C motif chemokine 5,Inverse variance weighted,8,1.14 [0.82-1.58],0.441564575898731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NECTIN4,Nectin-4,Inverse variance weighted,4,1.08 [0.89-1.32],0.443222716597722,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SPON2,Spondin-2,Inverse variance weighted,3,0.88 [0.64-1.22],0.444798128198759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.02 [0.96-1.09],0.446188737247227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,8,0.94 [0.81-1.1],0.447155257688969,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,0.91 [0.72-1.16],0.4500896156124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.02 [0.97-1.07],0.450314789968946,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADH1B,All-trans-retinol dehydrogenase,Wald ratio,1,0.92 [0.74-1.15],0.45493172689567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAT,Linker for activation of T-cells family member 1,Inverse variance weighted,2,0.91 [0.71-1.17],0.455088843261077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GUCA2A,Guanylin,Inverse variance weighted,7,0.94 [0.81-1.1],0.457559745261875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,0.97 [0.88-1.06],0.459626081391365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,L1CAM,Neural cell adhesion molecule L1,Inverse variance weighted,21,1.05 [0.92-1.2],0.461386848738733,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,0.97 [0.89-1.05],0.462357012103027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.07 [0.9-1.27],0.466597109657834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NFKBIE,NF-kappa-B inhibitor epsilon,Wald ratio,1,0.91 [0.7-1.18],0.468924140422427,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,Inverse variance weighted,4,0.97 [0.89-1.06],0.470989261435634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,19,0.96 [0.87-1.07],0.47466980852297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CTSF,Cathepsin F,Inverse variance weighted,27,1.03 [0.95-1.13],0.475492620070288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TOP2B,DNA topoisomerase 2-beta,Wald ratio,1,0.86 [0.57-1.3],0.475719839777434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DPT,Dermatopontin,Inverse variance weighted,4,1.07 [0.88-1.3],0.476169749384932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.98 [0.91-1.05],0.477235428216041,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,0.94 [0.8-1.11],0.47736268682832,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.97 [0.9-1.05],0.477729584255496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,1.03 [0.95-1.12],0.477774472894225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.07 [0.88-1.3],0.478201982720517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,WNT9A,Protein Wnt-9a,Wald ratio,1,1.17 [0.75-1.83],0.484192279678738,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,0.89 [0.64-1.24],0.489110357355461,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.17 [0.75-1.84],0.490241731048822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,1.01 [0.98-1.05],0.490479139156316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PENK,Proenkephalin-A,Inverse variance weighted,15,1.03 [0.95-1.11],0.493109427146198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.97 [0.89-1.06],0.496220804981618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,59,1.01 [0.98-1.04],0.496252479047566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.98 [0.94-1.03],0.496799385889685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.93 [0.76-1.14],0.49771502692443,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.91 [0.69-1.19],0.498113780267724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,1.03 [0.94-1.13],0.498927622071251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.98 [0.93-1.03],0.49916339933251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MDK,Midkine,Inverse variance weighted,14,0.97 [0.89-1.06],0.500007826154319,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.95 [0.81-1.11],0.503015593006793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,1.01 [0.98-1.03],0.505064536098979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.94 [0.79-1.12],0.506560472792279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.94 [0.79-1.12],0.506722472819101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GBP1,Guanylate-binding protein 1,Inverse variance weighted,4,1.04 [0.92-1.18],0.508769041850537,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.08 [0.85-1.38],0.509658508452228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.97 [0.88-1.07],0.509777380029313,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HJV,Hemojuvelin,Inverse variance weighted,2,0.73 [0.28-1.88],0.511605415889203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.83 [0.47-1.45],0.514338373920906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.99 [0.96-1.02],0.516062122574716,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.02 [0.97-1.07],0.517443662793362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,0.98 [0.91-1.05],0.52167857459853,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.9 [0.65-1.24],0.521881436776032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.07 [0.86-1.33],0.521932465153273,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLUL1,Clusterin-like protein 1,Inverse variance weighted,7,0.88 [0.6-1.29],0.522122655379871,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SDC1,Syndecan-1,Inverse variance weighted,12,1.04 [0.93-1.16],0.522985715569755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,0.95 [0.82-1.1],0.523440124868042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.06 [0.88-1.28],0.524593096222019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.96 [0.86-1.08],0.525855421737785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ELN,Elastin,Inverse variance weighted,10,1.12 [0.78-1.61],0.526213748847524,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,Wald ratio,1,0.75 [0.31-1.83],0.528039246574113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,0.93 [0.75-1.16],0.530958869311362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Inverse variance weighted,14,0.93 [0.73-1.18],0.531778507996069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,0.98 [0.92-1.04],0.532144915168937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.09 [0.84-1.4],0.532773466216385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.05 [0.89-1.25],0.535838157263218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,35,0.99 [0.95-1.03],0.536369154197267,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PPP3R1,Calcineurin subunit B type 1,Inverse variance weighted,3,1.06 [0.87-1.29],0.536981086120485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SIAE,Sialate O-acetylesterase,Inverse variance weighted,6,0.94 [0.76-1.15],0.538080343751722,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ICAM4,Intercellular adhesion molecule 4,Inverse variance weighted,58,1.01 [0.98-1.04],0.538135142318021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.17 [0.7-1.95],0.541673829727907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MCAM,Cell surface glycoprotein MUC18,Inverse variance weighted,11,0.97 [0.87-1.07],0.541718073717777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD36,Platelet glycoprotein 4,Inverse variance weighted,22,0.95 [0.82-1.11],0.545210242693404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OXT,Oxytocin-neurophysin 1,Inverse variance weighted,10,1.05 [0.9-1.23],0.545964339192879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD276,CD276 antigen,Inverse variance weighted,24,0.98 [0.92-1.04],0.547737457290053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.98 [0.93-1.04],0.547884701252944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CTSD,Cathepsin D,Inverse variance weighted,7,1.06 [0.88-1.27],0.549826547048879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OSM,Oncostatin-M,Inverse variance weighted,6,0.97 [0.87-1.08],0.55008444815011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.13 [0.76-1.68],0.550586351857802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.94 [0.77-1.15],0.551876949992741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,1.03 [0.93-1.15],0.55290065053347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,UPB1,Beta-ureidopropionase,Wald ratio,1,1.32 [0.52-3.37],0.554700834296949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DKK1,Dickkopf-related protein 1,Inverse variance weighted,12,0.97 [0.87-1.08],0.554896353245816,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CPA1,Carboxypeptidase A1,Inverse variance weighted,26,0.98 [0.9-1.06],0.555197477252342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,1.03 [0.93-1.15],0.555528225060895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PPY,Pancreatic prohormone,Inverse variance weighted,23,0.98 [0.91-1.05],0.557861653656828,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,0.93 [0.75-1.17],0.55862026918983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EGFLAM,Pikachurin,Wald ratio,1,1.16 [0.7-1.93],0.559937378248951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TFF3,Trefoil factor 3,Inverse variance weighted,10,0.98 [0.9-1.06],0.561148315082195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PYY,Peptide YY,Inverse variance weighted,16,1.02 [0.96-1.07],0.561374478061792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.96 [0.84-1.1],0.561432142211418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SSNA1,Sjoegren syndrome nuclear autoantigen 1,Wald ratio,1,0.89 [0.59-1.33],0.562822959410057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.05 [0.88-1.26],0.56380424503508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD99,CD99 antigen,Inverse variance weighted,4,0.9 [0.64-1.28],0.563846882338879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",Inverse variance weighted,18,0.98 [0.92-1.04],0.566134364634304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,UMOD,Uromodulin,Inverse variance weighted,34,0.98 [0.9-1.06],0.566782879819269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.94 [0.77-1.16],0.567238141996483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.06 [0.87-1.28],0.567753561686979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,4,1.05 [0.89-1.23],0.568343577955765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.99 [0.95-1.03],0.56947067713477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C4BPB,C4b-binding protein beta chain,Inverse variance weighted,21,1.03 [0.92-1.16],0.572063723887875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.03 [0.93-1.14],0.572411028952826,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Wald ratio,1,1.12 [0.76-1.64],0.57634692922042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,0.95 [0.79-1.14],0.576556792141055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SMAD2,Mothers against decapentaplegic homolog 2,Wald ratio,1,1.19 [0.65-2.16],0.579691120747019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,14,1.03 [0.93-1.14],0.580833958009174,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.93 [0.71-1.21],0.583606490610933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.02 [0.95-1.09],0.586448653732972,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,C5,Complement C5,Inverse variance weighted,3,1.03 [0.93-1.14],0.587007549553838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADAMTSL5,ADAMTS-like protein 5,Inverse variance weighted,3,1.03 [0.91-1.17],0.593022031871935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,1.01 [0.96-1.07],0.594982590417227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTH,Parathyroid hormone,Inverse variance weighted,11,1.07 [0.84-1.35],0.595384592133119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,0.98 [0.91-1.06],0.595411343962118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,1.01 [0.98-1.04],0.595541873001313,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.03 [0.91-1.18],0.599493182256219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,4,1.05 [0.86-1.29],0.600755100127351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FUOM,Fucose mutarotase,Inverse variance weighted,6,1.04 [0.91-1.18],0.60396924952332,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,REN,Renin,Inverse variance weighted,8,0.96 [0.82-1.12],0.604364893394699,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SARG,Specifically androgen-regulated gene protein,Wald ratio,1,0.95 [0.76-1.17],0.604430367473423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,10,1.05 [0.88-1.25],0.606158719299076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,14,1.02 [0.95-1.1],0.607715257314534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,A1BG,Alpha-1B-glycoprotein,Inverse variance weighted,4,1.07 [0.82-1.4],0.607918368692087,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.23 [0.56-2.71],0.610023426557084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MET,Hepatocyte growth factor receptor,Inverse variance weighted,21,1.03 [0.91-1.16],0.610993823945328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LYN,Tyrosine-protein kinase Lyn,Inverse variance weighted,2,1.04 [0.88-1.23],0.615313179305469,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,20,1.02 [0.95-1.09],0.61710659836541,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.94 [0.75-1.19],0.61883186543938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MUC13,Mucin-13,Inverse variance weighted,3,0.92 [0.67-1.27],0.620740588321816,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.05 [0.86-1.29],0.620950891035131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CFP,Properdin,Inverse variance weighted,17,1.01 [0.96-1.07],0.625633755104233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.25 [0.51-3.11],0.625843911371147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,0.97 [0.88-1.08],0.626403926570565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APP,Amyloid-beta precursor protein,Inverse variance weighted,10,1.03 [0.91-1.18],0.627094791460509,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,Wald ratio,1,1.09 [0.76-1.58],0.627747534077781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTN,Pleiotrophin,Inverse variance weighted,3,0.96 [0.81-1.14],0.627831656628802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HMOX2,Heme oxygenase 2,Inverse variance weighted,3,0.96 [0.81-1.14],0.628518769238971,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CRISP3,Cysteine-rich secretory protein 3,Inverse variance weighted,65,0.99 [0.95-1.03],0.629093925158324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MBL2,Mannose-binding protein C,Inverse variance weighted,42,1.01 [0.98-1.04],0.629272095303269,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,Wald ratio,1,1.1 [0.74-1.65],0.632745112153109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KLK4,Kallikrein-4,Inverse variance weighted,5,0.89 [0.56-1.42],0.635354708732242,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CFC1,Cryptic protein,Inverse variance weighted,11,0.98 [0.88-1.08],0.638678870268338,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,16,0.98 [0.89-1.08],0.63945665009356,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HEXIM1,Protein HEXIM1,Inverse variance weighted,2,0.94 [0.72-1.22],0.64140036913452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GLA,Alpha-galactosidase A,Inverse variance weighted,2,0.93 [0.68-1.27],0.642121821383227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,F9,Coagulation factor IX,Inverse variance weighted,3,1.07 [0.8-1.44],0.643335473695862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,0.93 [0.68-1.27],0.643621064342099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COLEC12,Collectin-12,Inverse variance weighted,3,1.13 [0.66-1.95],0.647264827743833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CEMIP2,Cell surface hyaluronidase,Inverse variance weighted,4,1.04 [0.89-1.21],0.64729229062785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.95 [0.77-1.17],0.650227365811971,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,1.01 [0.97-1.06],0.653593038822312,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.04 [0.88-1.23],0.654053544475029,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,1.09 [0.75-1.57],0.654620167204223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CSTB,Cystatin-B,Inverse variance weighted,23,0.99 [0.95-1.03],0.655348605167209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,18,1.01 [0.97-1.05],0.658705786375192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GCG,Pro-glucagon,Inverse variance weighted,2,1.06 [0.81-1.41],0.660444757503875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,1.02 [0.95-1.09],0.662599665610024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FAM3D,Protein FAM3D,Inverse variance weighted,38,1.01 [0.97-1.05],0.669069399318719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.96 [0.81-1.15],0.669275531306969,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACE,Angiotensin-converting enzyme,Inverse variance weighted,27,1.01 [0.97-1.04],0.669896320752001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.05 [0.84-1.31],0.67050187838504,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DCN,Decorin,Inverse variance weighted,2,0.88 [0.49-1.59],0.67208837689263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CALCA,Calcitonin,Inverse variance weighted,13,1.03 [0.91-1.16],0.674273953617242,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.02 [0.92-1.14],0.674286193341608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.03 [0.91-1.16],0.674678799363203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.93 [0.66-1.31],0.681354554362136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,S100P,Protein S100-P,Inverse variance weighted,4,1.05 [0.84-1.31],0.682059774688518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RSPO3,R-spondin-3,Inverse variance weighted,5,0.94 [0.69-1.28],0.682129396588414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LBR,Delta(14)-sterol reductase LBR,Inverse variance weighted,2,1.05 [0.82-1.35],0.682834613022671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.98 [0.88-1.09],0.685568999825012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.61 [0.06-6.7],0.686295372134494,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.98 [0.9-1.07],0.686966650268827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.89 [0.5-1.57],0.687838902065896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAMB1,Laminin subunit beta-1,Inverse variance weighted,21,0.98 [0.9-1.07],0.690411584385606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GSTA3,Glutathione S-transferase A3,Inverse variance weighted,2,0.76 [0.19-2.96],0.691261029055415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PROC,Vitamin K-dependent protein C,Inverse variance weighted,40,1.01 [0.96-1.07],0.692945316519755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,1.04 [0.84-1.29],0.693431632177499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CFH,Complement factor H,Inverse variance weighted,7,0.97 [0.85-1.11],0.694349090507858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.92 [0.59-1.42],0.694909121944214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL17C,Interleukin-17C,Inverse variance weighted,5,0.96 [0.76-1.2],0.699886793429617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,0.99 [0.95-1.04],0.700053312539817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TCOF1,Treacle protein,Wald ratio,1,1.08 [0.74-1.56],0.700162541352611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,POF1B,Protein POF1B,Inverse variance weighted,4,0.97 [0.85-1.12],0.702663998373727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DCXR,L-xylulose reductase,Inverse variance weighted,9,1.06 [0.78-1.45],0.703505688840565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TF,Serotransferrin,Inverse variance weighted,6,0.92 [0.59-1.42],0.703646939298636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EPPK1,Epiplakin,Inverse variance weighted,30,0.99 [0.96-1.03],0.70461682779451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,1 [0.98-1.02],0.707489261097499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SNCG,Gamma-synuclein,Inverse variance weighted,47,1 [0.97-1.02],0.707597051776709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.03 [0.89-1.19],0.710343769144418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,0.98 [0.88-1.09],0.714531360840589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AFM,Afamin,Inverse variance weighted,8,1.03 [0.89-1.19],0.715021442323976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,XCL1,Lymphotactin,Inverse variance weighted,15,0.98 [0.89-1.08],0.715113280955653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",Inverse variance weighted,4,1.03 [0.89-1.18],0.716900645898311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD63,CD63 antigen,Inverse variance weighted,12,0.98 [0.86-1.11],0.717688429177742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PAXX,Protein PAXX,Wald ratio,1,1.03 [0.86-1.24],0.71807417107825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,8,1.02 [0.93-1.11],0.718512645363479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OGN,Mimecan,Inverse variance weighted,37,1.01 [0.97-1.05],0.722551865816044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.01 [0.94-1.09],0.722654850059118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.96 [0.75-1.22],0.722992220740338,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1 [0.98-1.03],0.723248219887,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,1.02 [0.92-1.12],0.725462152116087,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ASS1,Argininosuccinate synthase,Inverse variance weighted,2,0.96 [0.77-1.2],0.726215077830959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Wald ratio,1,0.93 [0.61-1.41],0.726247200961927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MVK,Mevalonate kinase,Wald ratio,1,1.15 [0.52-2.56],0.727085328833724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,Wald ratio,1,1.15 [0.52-2.56],0.727085328833724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TALDO1,Transaldolase,Wald ratio,1,1.15 [0.52-2.54],0.727085328833724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HEG1,Protein HEG homolog 1,Inverse variance weighted,14,1.03 [0.88-1.19],0.727459792498068,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.96 [0.75-1.22],0.727601762122028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.98 [0.87-1.1],0.731435827704311,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.04 [0.83-1.3],0.731913340223055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1.01 [0.94-1.09],0.73710194463448,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,17,0.99 [0.92-1.06],0.737457071883706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.02 [0.9-1.16],0.740470749491342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NUDT16,U8 snoRNA-decapping enzyme,Inverse variance weighted,4,0.96 [0.74-1.23],0.74226456559398,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,0.98 [0.87-1.11],0.74233395178435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACAN,Aggrecan core protein,Inverse variance weighted,30,1.02 [0.93-1.11],0.742946758447051,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAT2,Linker for activation of T-cells family member 2,Inverse variance weighted,3,1.13 [0.54-2.39],0.744405699308203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RTBDN,Retbindin,Inverse variance weighted,2,1.09 [0.63-1.88],0.749428295675078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCG3,Secretogranin-3,Inverse variance weighted,16,1.02 [0.92-1.12],0.750176882644264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MME,Neprilysin,Inverse variance weighted,46,1.01 [0.96-1.05],0.753159269300119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CTSS,Cathepsin S,Inverse variance weighted,7,1.02 [0.89-1.17],0.753553300305406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PLTP,Phospholipid transfer protein,Inverse variance weighted,30,1.01 [0.94-1.08],0.753675364576882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,0.96 [0.76-1.23],0.756092653576774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.04 [0.81-1.33],0.756184014312573,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LAMP2,Lysosome-associated membrane glycoprotein 2,Inverse variance weighted,6,0.95 [0.7-1.29],0.756476947126912,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,20,0.98 [0.83-1.14],0.758068936531742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,1 [0.98-1.03],0.760505980770411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCLY,Selenocysteine lyase,Inverse variance weighted,4,1.03 [0.85-1.25],0.763265227573161,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANXA2,Annexin A2,Inverse variance weighted,2,1.1 [0.6-1.99],0.763786608816147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.03 [0.83-1.28],0.765480193657081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.98 [0.85-1.13],0.767511794811007,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.03 [0.85-1.24],0.769148779275854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.01 [0.95-1.08],0.769428090159934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DNAJB1,DnaJ homolog subfamily B member 1,Inverse variance weighted,2,1.02 [0.88-1.18],0.772395492518737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,0.99 [0.95-1.04],0.773190008061253,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,1.05 [0.74-1.49],0.77668788080686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MMP10,Stromelysin-2,Wald ratio,1,0.94 [0.63-1.41],0.777308260537912,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,0.99 [0.94-1.05],0.777444773996138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CHAD,Chondroadherin,Inverse variance weighted,15,0.99 [0.94-1.05],0.778170223480606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ENO3,Beta-enolase,Inverse variance weighted,3,0.97 [0.77-1.21],0.778475052049726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,0.96 [0.73-1.27],0.778860081476475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,1.04 [0.81-1.32],0.782254062613241,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,0.99 [0.93-1.06],0.783130696745259,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.97 [0.81-1.17],0.784616837542994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.99 [0.91-1.07],0.786514246326329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD160,CD160 antigen,Inverse variance weighted,24,0.99 [0.93-1.05],0.79326083834918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SHBG,Sex hormone-binding globulin,Inverse variance weighted,11,1.02 [0.91-1.14],0.795783404068499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TMPRSS15,Enteropeptidase,Inverse variance weighted,11,1.02 [0.87-1.2],0.796228417581281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.97 [0.78-1.21],0.796690666608968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.98 [0.81-1.17],0.800815092134407,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.03 [0.81-1.31],0.801376673659946,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ITGA11,Integrin alpha-11,Inverse variance weighted,7,1.04 [0.78-1.39],0.803036427224164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.06 [0.67-1.69],0.805171156180858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.98 [0.84-1.15],0.806568950034309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.97 [0.75-1.26],0.810519154148545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.98 [0.85-1.13],0.812945308560476,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ATRN,"Attractin, Isoform 2",Inverse variance weighted,8,0.96 [0.68-1.36],0.813210530704732,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PSRC1,Proline/serine-rich coiled-coil protein 1,Inverse variance weighted,5,0.97 [0.77-1.22],0.813220657554059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.02 [0.87-1.2],0.817155371275223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FAM3B,Protein FAM3B,Inverse variance weighted,26,1 [0.97-1.04],0.818625870328927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CHGB,Secretogranin-1,Inverse variance weighted,7,1.01 [0.9-1.15],0.818940887347679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SMAD1,Mothers against decapentaplegic homolog 1,Wald ratio,1,0.96 [0.66-1.38],0.820601226438481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.01 [0.95-1.07],0.822230509639378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.99 [0.88-1.11],0.82246588381163,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.98 [0.86-1.13],0.822487942457688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.02 [0.88-1.18],0.82341905674528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.01 [0.95-1.06],0.831803295909291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DSC2,Desmocollin-2,Inverse variance weighted,16,0.99 [0.95-1.04],0.832258919219851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.98 [0.82-1.17],0.832979997806763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.88 [0.25-3.05],0.838244533285176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.02 [0.82-1.28],0.840420552829636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CHGA,Chromogranin-A,Inverse variance weighted,5,1.02 [0.87-1.19],0.840509587780815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,0.97 [0.74-1.28],0.842301886456961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MMP8,Neutrophil collagenase,Inverse variance weighted,10,1.01 [0.93-1.1],0.844442470528298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GRP,Gastrin-releasing peptide,Inverse variance weighted,21,1.01 [0.95-1.07],0.847773482028172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,1.02 [0.8-1.31],0.85045953970593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,OCLN,Occludin,Inverse variance weighted,2,1.03 [0.73-1.46],0.852406621738989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.01 [0.95-1.07],0.85380567468473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FGFBP3,Fibroblast growth factor-binding protein 3,Inverse variance weighted,43,0.99 [0.94-1.06],0.854958353307491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.98 [0.78-1.22],0.855292803360968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,F10,Coagulation factor X,Inverse variance weighted,11,0.99 [0.87-1.12],0.857054320612584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.02 [0.85-1.21],0.858899990702492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.02 [0.84-1.23],0.859901126057034,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DNMBP,Dynamin-binding protein,Inverse variance weighted,5,0.98 [0.81-1.2],0.860298376926144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,INHBC,Inhibin beta C chain,Inverse variance weighted,12,1.01 [0.91-1.12],0.860595713816764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPINE1,Plasminogen activator inhibitor 1,Inverse variance weighted,5,1.02 [0.8-1.31],0.861795298817457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ANGPTL2,Angiopoietin-related protein 2,Inverse variance weighted,12,1.02 [0.85-1.21],0.862015154238587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,0.99 [0.91-1.08],0.862984895618293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACY1,Aminoacylase-1,Inverse variance weighted,6,0.99 [0.88-1.11],0.864327580788401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,1.02 [0.82-1.26],0.868919933038836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL10,Interleukin-10,Inverse variance weighted,4,0.99 [0.93-1.06],0.869707732905628,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PGF,Placenta growth factor,Inverse variance weighted,5,0.98 [0.79-1.23],0.870618257769008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LPA,Apolipoprotein(a),Inverse variance weighted,2,1.01 [0.85-1.21],0.87112745271351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GSN,Gelsolin,Inverse variance weighted,7,0.99 [0.86-1.13],0.8722293965534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DNPEP,Aspartyl aminopeptidase,Inverse variance weighted,4,0.98 [0.77-1.26],0.872568473769827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HMOX1,Heme oxygenase 1,Inverse variance weighted,20,1.01 [0.89-1.15],0.875383956988252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,0.95 [0.53-1.73],0.876096296655577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HBEGF,Proheparin-binding EGF-like growth factor,Inverse variance weighted,22,1.01 [0.92-1.1],0.876284081050135,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,0.99 [0.87-1.13],0.876305231601354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL15,Interleukin-15,Inverse variance weighted,35,1 [0.96-1.05],0.879435030638184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,26,0.99 [0.91-1.08],0.879511858219555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,Inverse variance weighted,3,1.01 [0.89-1.14],0.880387310757406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.01 [0.85-1.21],0.882596436907565,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,0.99 [0.91-1.09],0.884757167720235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.98 [0.76-1.27],0.889888601227165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NTF3,Neurotrophin-3,Inverse variance weighted,11,1.01 [0.86-1.19],0.891902257678093,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PVR,Poliovirus receptor,Inverse variance weighted,3,1.03 [0.63-1.71],0.89394893342874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,1.01 [0.9-1.13],0.8966808629441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1 [0.95-1.05],0.898999711863789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SERPINB8,Serpin B8,Inverse variance weighted,29,1 [0.98-1.02],0.901799276590077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1 [0.92-1.08],0.901831262348696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL22,C-C motif chemokine 22,Inverse variance weighted,8,1.01 [0.83-1.23],0.902576198344381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1 [0.93-1.06],0.903539616415959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,1 [0.92-1.09],0.908733665659497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.99 [0.87-1.13],0.909887002472316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,0.99 [0.91-1.09],0.909902658134733,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,Inverse variance weighted,19,1 [0.95-1.04],0.911131657956319,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,0.99 [0.78-1.25],0.913641286636083,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ABL1,Tyrosine-protein kinase ABL1,Inverse variance weighted,3,0.98 [0.66-1.44],0.91384184810198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,1.01 [0.87-1.16],0.915278528687994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CDH2,Cadherin-2,Inverse variance weighted,21,1.01 [0.84-1.22],0.917769368460153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MEP1A,Meprin A subunit alpha,Inverse variance weighted,28,1 [0.93-1.07],0.91832900563999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.99 [0.74-1.32],0.919763509834846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PSAP,Prosaposin,Inverse variance weighted,13,1 [0.92-1.08],0.921205156652547,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CD302,CD302 antigen,Inverse variance weighted,11,0.99 [0.89-1.11],0.92599938050212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NECTIN2,Nectin-2,Inverse variance weighted,3,0.99 [0.76-1.28],0.926596164491873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,1.01 [0.84-1.22],0.928551953521101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,1.01 [0.74-1.38],0.928879082788844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EEF1D,Elongation factor 1-delta,Wald ratio,1,1.01 [0.79-1.29],0.929943563885165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ASAH1,Acid ceramidase,Inverse variance weighted,4,1.01 [0.76-1.34],0.930192242367409,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1 [0.95-1.05],0.931408449015581,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.99 [0.7-1.39],0.933415475146952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PKD1,Polycystin-1,Inverse variance weighted,12,0.99 [0.81-1.22],0.934552555539156,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",Wald ratio,1,1.02 [0.69-1.5],0.936890873849874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1 [0.88-1.12],0.938969395455454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SELPLG,P-selectin glycoprotein ligand 1,Inverse variance weighted,14,0.99 [0.85-1.16],0.939184099249316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.99 [0.75-1.3],0.939330181257663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FTCD,Formimidoyltransferase-cyclodeaminase,Inverse variance weighted,6,1 [0.91-1.11],0.939407861757208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,10,0.99 [0.76-1.28],0.939835735359737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NOMO1,Nodal modulator 1,Inverse variance weighted,24,1 [0.97-1.03],0.939965367450446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",Inverse variance weighted,18,1 [0.9-1.11],0.940340193126669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LIPF,Gastric triacylglycerol lipase,Inverse variance weighted,24,1 [0.95-1.06],0.941855818022511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PRSS8,Prostasin,Inverse variance weighted,14,1 [0.88-1.12],0.942163559186903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SEC31A,Protein transport protein Sec31A,Wald ratio,1,0.99 [0.69-1.41],0.944813582661424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LEP,Leptin,Inverse variance weighted,4,1.03 [0.48-2.22],0.946919402185392,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CHMP6,Charged multivesicular body protein 6,Wald ratio,1,1 [0.91-1.09],0.948039301575086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,VSNL1,Visinin-like protein 1,Inverse variance weighted,9,1 [0.92-1.08],0.949301562393534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SOST,Sclerostin,Inverse variance weighted,31,1 [0.93-1.07],0.949763097532321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,1 [0.87-1.13],0.951646704125888,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CALB1,Calbindin,Inverse variance weighted,9,1 [0.88-1.13],0.952027836465051,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.99 [0.76-1.3],0.952201737800447,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.99 [0.78-1.26],0.953687667955923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PALM,Paralemmin-1,Inverse variance weighted,4,1.01 [0.79-1.28],0.95375228053599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1 [0.97-1.03],0.954772137347584,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ORM1,Alpha-1-acid glycoprotein 1,Inverse variance weighted,21,1 [0.92-1.09],0.956616603643111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1 [0.85-1.16],0.957454374516585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,0.99 [0.77-1.28],0.961504652903178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1 [0.81-1.25],0.96439573155964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",Inverse variance weighted,2,0.96 [0.19-4.8],0.964716924914665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,Wald ratio,1,0.99 [0.68-1.45],0.967627138825979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1 [0.88-1.14],0.968109599572648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SEPTIN8,Septin-8,Inverse variance weighted,4,1.01 [0.76-1.33],0.968200386261417,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1 [0.93-1.08],0.974678249234783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,1 [0.94-1.06],0.975538921747986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,Inverse variance weighted,2,0.99 [0.59-1.68],0.980713668986067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,IL18,Interleukin-18,Inverse variance weighted,26,1 [0.93-1.07],0.980928769144177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1 [0.87-1.16],0.981859002220828,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,NUDT5,ADP-sugar pyrophosphatase,Wald ratio,1,1 [0.71-1.42],0.981921750098478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1 [0.82-1.22],0.982725118090943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,PTP4A3,Protein tyrosine phosphatase type IVA 3,Inverse variance weighted,6,1 [0.94-1.07],0.983571606250142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,MB,Myoglobin,Inverse variance weighted,9,1 [0.87-1.15],0.98426681048358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,1 [0.76-1.33],0.985153153929024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CDH1,Cadherin-1,Inverse variance weighted,16,1 [0.93-1.08],0.985990190290005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.99 [0.44-2.22],0.986187831296892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",Inverse variance weighted,2,1 [0.86-1.16],0.986538844278772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ADA,Adenosine deaminase,Inverse variance weighted,22,1 [0.98-1.03],0.987841078054055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CCN5,CCN family member 5,Inverse variance weighted,12,1 [0.95-1.06],0.988845607096617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1 [0.86-1.16],0.989789095334415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,LGMN,Legumain,Inverse variance weighted,22,1 [0.85-1.17],0.993240231519998,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,1 [0.71-1.42],0.994202875014365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,DBI,Acyl-CoA-binding protein,Wald ratio,1,1 [0.81-1.24],0.995181728230599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SCG2,Secretogranin-2,Inverse variance weighted,2,1 [0.53-1.87],0.996380690796464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,SIT1,Signaling threshold-regulating transmembrane adapter 1,Inverse variance weighted,7,1 [0.79-1.27],0.996972929950452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1 [0.72-1.38],0.998712464704385,trans
